SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
Date of report (Date of earliest event reported): February 27, 2014
Delaware 000-6658 04-2217279 _______________ ____________ __________________ (State or other (Commission (IRS Employer No.) jurisdiction of File Number) incorporation) 70 Orville Drive |
ITEM 1.01
See Item 2.01 for information as to an Asset Purchase Agreement, dated February 26, 2014.
ITEM 2.01 Completion of Acquisition or Disposition of Assets
On February 26, 2014, the Company acquired the assets related to
the laboratory and pharmacy balance and digital scale business
(the "Digital Scale Business") of Fulcrum Inc., (the "Assignor")
pursuant to an Asset Purchase Agreement (?APA?) with the seller
and its principal stockholders, James Maloy and Karl Nowosielski.
Pursuant to the APA the consideration paid and payable by the Company to Fulcrum Inc., consisted of $430,000 in cash, 126,449 shares of the Company's Common Stock valued at $427,500 (of which 31,612 shares are held in a one year escrow to secure the seller's representations and warranties), based on the average of the per share selling prices of the Common Stock in the last five transactions prior to the Closing on the Over-the-Counter Market Bulletin Board and the obligation to pay percentages of net sales of the related products sold by the Company during the periods ending June 30, 2014 (8%), June 30, 2015 (9%), June 30, 2016 (10%) and June 30, 2017 (11%). The Company agreed to provide Fulcrum "piggy-back" registration rights with respect to the shares issued.
James Maloy, the Seller?s President, and Karl Nowosielski, the Chief Operating Officer entered into long term non-competition agreements with the Company pursuant to which each was paid $135,000. Maloy and Nowosielski agreed to non-competition covenants for five and four year periods, respectively. Mr. Nowosielski also entered into an employment agreement providing for his employment as President of the Company's new Torbal Scales Division and the Director of Marketing of the Company for a three-year term, which may be extended by mutual consent for an additional two years. His annual salary is to be $140,000, subject to increases commencing with the second year based on percentage increases in the Consumer Price Index from the end of the immediately preceding year's CPI plus such bonuses which the Board of Directors in its sole and absolute discretion my authorize. Pursuant to the employment agreement he was granted at the Closing under the Company's 2012 Stock Option Plan qualified stock options to purchase 2,000 shares of Common Stock at a price of $3.66 per share and is to be granted subject to his continued employment in February 26, 2015, 2016, and 2017 QSOs for 4,000 shares, 5,000 shares and 6,000 shares, respectively. The employment agreement contains a non-competition covenant, subject to the Company not being in default thereof for an 12 month period following his last day of his employment in the United States, Canada, Central and South America.
The Company also entered into an agreement with the principal supplier to Fulcrum Inc., to be the Company's sole supplier for the Digital Scale Products and for the Company to be the exclusive distributor of the supplier of the products in the United States and Canada. The termination date of the agreement is March 1, 2020, but may be terminated upon a breach by the other party or by the supplier if the aggregate purchase price for the goods acquired is less than $150,000 for 2014 or $180,000 for any subsequent year during the term. Each party may terminate the agreement upon the bankruptcy, moratorium, receivership, liquidation or any agreement between the debtor and its creditors, or any circumstance likely to affect the party's ability to fulfill its obligations under the Supply Agreement.
As a result of the stock issuance, the Company's outstanding shares of Common Stock increased to 1,469,112 as of February 27, 2014.
Based on unaudited information the sales of the acquired business for its fiscal years ended June 30, 2012 and June 30, 2013 and the five months ended November 30, 2013 were $993,300, $1,140,000 and $417,500, respectively.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(a) Financial Statements of Business Acquired
Fulcrum Inc., was unable to provide audited historical financial statements for its fiscal years ended June 30, 2012 and June 30, 2013 to the Company or the information which would enable the Company without material expense to have them prepared.
(b) Pro Forma Financial Information
The Company intends to file pro forma financial information under cover of Form 8-K/A no later than 71 calendar days after the date this Report was required to be filed.
(c) Exhibits Exhibit No. Exhibit __________ _________________________ 2.1 Copy of Asset Purchase Agreement dated February 26, 2014 among the Company, Fulcrum Inc., James Maloy and Karl Nowosielski.* 10(b) Copy of Non-Competition Agreement with James Maloy. 10(c) Copy of Non-Competition Agreement with Karl Nowosielski. 10(d) Copy of Registration Rights Agreement. 10(e) Copy of Escrow Agreement. 10(f) Copy of Employment Agreement with Karl Nowosielski. 10(g) Copy of Supply Contract with Axis Sp 3.O.O _______________________________________________________________ |
*Disclosure Schedules to this Exhibit have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish supplemental copies of any of the omitted Disclosure Schedules to the SEC upon request.
The lessor of the premises leased by the suppler has agreed to the assignment to the Company of the lease as of June 30, 2014 for which agreement the Company contributed to the termination fees.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SCIENTIFIC INDUSTRIES, INC.
(Registrant)
Date: February 28, 2014 By: /s/ Helena R. Santos ________________________ |
Helena R. Santos, President and Chief Executive Officer
ASSET PURCHASE AGREEMENT
DATED AS OF
FEBRUARY 26, 2014
BETWEEN
SCIENTIFIC INDUSTRIES, INC.
AND
FULCRUM, INC.
AND
JAMES MALOY
AND
KARL NOWOSIELSKI
List of Exhibits and Disclosure Schedule
Exhibit A - Supply and Distribution Agreement Exhibit B - Form of Employment Agreement Exhibit C - Form of Non-Competition Agreement Exhibit D - Form of Legal Opinion of Jeffrey Marks, Esq. Exhibit E - Form of Registration Agreement
Disclosure Schedule
ASSET PURCHASE AGREEMENT
THIS ASSET PURCHASE AGREEMENT is made this 26th day of February 2014 by and among SCIENTIFIC INDUSTRIES, INC., a Delaware Corporation ("Assignee"), FULCRUM, INC., a New Jersey corporation ("Assignor") and JAMES MALOY and KARL NOWOSIELSKI ("KN"), each a major stockholder of Assignor (each a "Major Stockholder" and collectively, the "Major Stockholders").
WHEREAS, Assignor owns and desires to sell and assign to Assignee and Assignee desires to acquire from Assignor all of the assets of Assignor related to Assignor's laboratory and pharmacy balance and digital scale business (other than the Excluded Assets as herein defined); and
NOW THEREFORE, in consideration of the foregoing and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties hereby agree as follows:
1. Definitions.
1.1. Definitions. In addition to the terms
defined elsewhere in this Agreement, including the recitals, the
following terms, when used herein, shall have the following
meanings:
(a) "Accounts Receivable" shall mean money
due for all Company sales that have shipped prior to the Closing
Date from Assignor to the relevant customers. "Accounts Receivable"
shall not include sales made prior to the Closing Date that have not
shipped on or prior to Closing"
(b) "Acquired Assets" shall have the meaning set forth in Section 2.1 below.
(c) "Acquisition" shall mean the purchase of the Acquired Assets and the other transactions contemplated by this Agreement and the other Related Documents.
(d) "Affiliate" shall mean a person that directly or indirectly, through one or more intermediaries, controls or is controlled by, or is under common control with, the person specified or, with respect to an individual, a family member or relative. For purposes of this definition, the terms "control," "controlled by" and "under common control with" shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such person and, in the case of an entity, shall require (i) in the case of a corporate entity, direct or indirect ownership of at least a majority of the securities having the right to vote for the election of directors, and (ii) in the case of a non-corporate entity, direct or indirect ownership of at least a majority of the equity interests with the power to direct the management and policies of such non-corporate entity.
(e) "Agreement," "this Agreement," "hereto," "hereof," "hereunder," "hereby," and similar expressions refer to this Agreement as a whole, including the schedules,
appendices and exhibits attached hereto, and not any particular article, section, subsection or other subdivision hereof or thereof.
(f) "Assignor-Related Claims" shall mean claims
arising out of or connected or substantially related to (i) the
ownership or the Exploitation of any Acquired Asset by or on behalf of
Assignor or any Assignor Affiliate on or before the Closing Date or
(ii) the operation of any business by or on behalf of Assignor or any
Assignor Affiliate at any time with respect to the Acquired Assets.
(g) "Assumed Contracts" shall mean the contracts listed in Section 1.1(g) of the Disclosure Schedule.
(h) "Balance and Scale Business" shall mean the research, development, production, marketing and sale of the laboratory, analytical and pharmacy balance and digital scale products, including the Torbal DrX3 mechanical scale, pill counters, moisture analyzers, industrial scales, force gauges, systems, methods and processes with respect to the business of Assignor prior to Closing and Assignee post-Closing.
(i) "Closing Inventory Value" means the value of the Inventory as of the Closing Date as mutually agreed by Assignor and Assignee.
(j) "Code" shall mean the United States Internal Revenue Code of 1986, as amended.
(k) "Computer Code" shall mean hardware, firmware, and software, regardless of form (e.g., embedded logic, object code or source code) or language, where such hardware, firmware, and software performs logic or other operations or includes instructions, such that when executed, the instructions cause a computer or other data processing system to carry out logic or other operations.
(l) "Confidential Information" shall mean all
ideas and information of any kind that are held in confidence by one
person and transferred, disclosed or made available to a receiving
person and are identified at the time of disclosure as being proprietary
or confidential. The obligations in this Agreement with respect to
Confidential Information shall not apply to any portion of the
Confidential Information that the receiving person can demonstrate
by legally sufficient evidence (i) now or hereafter, through no act
or failure to act on the part of the receiving person, is or becomes
public; (ii) is known to the receiving person or one of its Affiliates
at the time such person receives such Confidential Information except
as a result of the person's employment or affiliation with Assignor;
(iii) is hereafter furnished to the receiving person by a third
person unrelated to the disclosing person without violating any
agreement with the disclosing person; or (iv) is independently
developed by the receiving person or one of its Affiliates without
use of any Confidential Information received from the other
person.
(m) "Copyrights" shall mean all original works
of authorship, including all copyrights and registrations or
applications for registration of copyrights in any jurisdiction,
including any renewals or extensions thereof, advertising materials,
publications,
technical papers and Computer Code, instructional brochures, and any right (whether by license or otherwise) to use any of the foregoing, that are owned, used or held for use by Assignor in connection with any Acquired Asset.
(n) "Disclosure of Invention" shall mean any written, oral or visual idea, concept or invention of Assignor, any Assignor Affiliate or any person from whom Assignor or any Assignor Affiliate has obtained intellectual property rights in any manner relating to an Acquired Asset, whether or not such idea, concept or invention has been filed as a patent application or submitted by the inventor(s) to any attorney, agent or other representative of Assignor or any Assignor Affiliate for evaluation as to patentability.
(o) "Disclosure Schedule" shall mean the lists and other information delivered by Assignor to Assignee in response to the requirements of Section 4.
(p) "Environmental Law" shall mean any Law relating to: (i) the protection or restoration of the environment, health, safety, or natural resources, (ii) the handling, use, presence, disposal, release or threatened release of any Hazardous Substance, or (iii) wetlands, indoor air, pollution, contamination or any injury or threat of injury to persons or property in connection with any Hazardous Substance.
(q) "Excluded Assets" shall mean the following assets of Assignor at the Closing: (i) cash and accounts receivables of Assignor; (ii) all business records of Assignor or any Assignor Affiliate not related to the Acquired Assets; (iii) Security Deposits; and (iv) such other assets set forth in Section 1.1(q) of the Disclosure Schedule not related to Assignor's Balance and Scale Business.
(r) "Exploit" or "Exploitation" shall mean, with respect to any product, invention, system, process, intellectual property or asset, to disclose, manufacture, produce, import, use, operate, research, design, develop, perform clinical or other testing, perform quality assurance testing, commercialize, revise, repair, register, maintain, modify, enhance, upgrade, prepare derivative works, seek regulatory concurrences or approvals, package, label, improve, formulate, export, transport, distribute, promote, market, advertise, sell, have sold, offer for sale or license such product, invention, intellectual property or asset, or to have another person do any of the same.
(s) "GAAP" means United States generally accepted accounting principles.
(t) "Governmental Authority" shall mean any nation, territory or government, foreign, domestic or multinational, any state, local or other political subdivision thereof, and any bureau, court, tribunal, board, commission, department, agency or other entity exercising executive, legislative, judicial, regulatory or administrative functions of government, including all Taxing authorities, the U.S. Patent and Trademark Office, and all U.S. and European bodies and all other entities exercising regulatory authority over Acquired Assets or devices.
(u) "Hazardous Substance" shall mean any
substance that is (i) listed, classified or regulated pursuant to
any Environmental Law, (ii) any petroleum product or by-product,
asbestos-containing material, lead-containing paint or plumbing,
polychlorinated biphenyls, radioactive materials or radon, or
(iii) any other substance which is the subject of regulatory
action by any Governmental Authority in connection with any
Environmental Law.
(v) "Initial Specifications" shall mean any and all patterns, plans, designs, research data, techniques, methods, formulae, specifications, Manufacturing Processes, vendor, raw material and component lists and specifications, quality testing procedures, process validations, environmental control documentation, design history files, operating manuals, blueprints, sketches, drawings, manuals, data, records, procedures, research and development records, compositions, improvements, proposals, technical and computer data and Computer Code and related documentation, process descriptions and other technical data (including without limitation design specifications, chemical formulations, standard operating procedures and manufacturing protocols) reasonably necessary for or used or held for use by or on behalf of Assignor or any Assignor Affiliate in connection with the Exploitation of any Acquired Asset, and all copies and tangible embodiments of the foregoing.
(w) "Insider" shall mean any stockholder, director or officer of Assignor or any Assignor Affiliate, or any Affiliate thereof.
(x) "Intellectual Property" means all patents, patent applications, and patent disclosures, together with all reissuances, continuations, continuations-in-part, revisions, extensions, and reexaminations thereof, trademarks, trade names, corporate names, goodwill associated therewith, and applications, registrations, certifications (including without limitation NTEP certifications) and renewals in connection therewith, copyrights and applications, registrations, and renewals in connection therewith, websites, mask works and applications, registrations, and renewals in connection therewith, trade secrets and confidential business information including ideas, research and development, know-how, formulae, compositions, manufacturing and production processes and techniques, technical data, designs, drawings, specifications, customer and supplier lists, pricing and cost information, computer software (including data and related documentation), other proprietary rights that are used in connection with or are necessary to the conduct of the Business by Assignor.
(y) "Inventory" means inventory as defined in accordance with GAAP including all inventory of raw materials components, finished goods, supplies and works-in-progress of Assignor, net of obsolete and non-salable items, at the Closing relating to the Balance and Scale Business including without limitation the inventory set forth in Section 1.1(y) of the Disclosure Schedule.
(z) "June 2013 Inventory Value" means $289,000.
(aa) "Knowledge" shall mean the knowledge, after due inquiry, of the officers (including the President, Chief Financial Officer and any person holding an office of vice president (or comparable office of authority) or above) and directors of Assignor and the technical employees of Assignor's business related to the Acquired Assets.
(bb) The term "Law" shall mean any federal, state, local, municipal, international, multinational, foreign or other law, statute, constitution, principle of common law, resolution, ordinance, code, order, edict, decree, rule, regulation, guideline, ruling requirement or other pronouncement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Authority.
(cc) The term "license" shall include not only rights granted under formal or informal license agreements, but also other rights to use (including rights granted by means of covenants not to sue).
(dd) "Lease" shall mean that certain Lease Agreement by and between Assignor and Telx Clifton-I, LLC (as successor to 3-21 Acquisitions, LLC and Palisades Plaza Associates, LP) dated as of November 1, 2007, as subsequently amended on August 17, 2011 for the Premises.
(ee) "Lien" shall mean any interest, consensual or otherwise, in property, whether real, personal or mixed, or assets, tangible or intangible, securing an obligation owed to, or a claim by a third person, or otherwise evidencing an interest of a person other than the owner of the property or asset, whether such interest is based on Law or contract, and including any security interest, security title, lien, mortgage, recordation of abstract of judgment, deed of trust, deed to secure debt, encumbrance, restriction, charge, covenant, legal or equitable claim, exception, encroachment, easement, right of way, license, permit, pledge, conditional sale, option, trust (constructive or otherwise) or trust receipt or a lease, consignment or bailment for security purposes or other title exception affecting any property or asset.
(ff) "Litigation Matter" shall mean any claim, investigation, arbitration, grievance, litigation, action, suit or proceeding, administrative or judicial, to which a Party is (or, to such Party's knowledge, is threatened to be made) a party, or relating to any Acquired Asset, or this Agreement (in each case whether such Party is a plaintiff, defendant or otherwise), at law or in equity or otherwise, or before any Governmental Authority.
(gg) "Manufacturing Processes" shall mean all processes related to the production of the Acquired Assets, including, as applicable: (i) flow charts and process descriptions, bills of materials, and method sheets of each and every process step for the manufacture of the Acquired Assets; and (ii) full and complete specifications on all equipment used specifically for the Acquired Assets, such as molds, gluing stations, fixtures, jigs and test equipment including software and Computer Code.
(hh) "Material Adverse Effect" shall mean any change, effect or circumstance that (i) is materially adverse to any Acquired Asset, (ii) materially impairs the ability of any Party to consummate the transactions contemplated by, or to perform its obligations under, this Agreement or any other Related Document, or otherwise materially impedes the consummation of the Acquisition or (iii) has a material adverse effect on the financial value of any Acquired Asset to Assignee or on the ability of Assignee to Exploit any Acquired Asset after the Closing.
(ii) "Net Sales" shall mean, with respect to a period, the gross sales less discounts, returns and allowances, freight, and taxes during such period in respect of the sale of products relating to the Balance and Scale Business, as determined in accordance with GAAP, including without limitation, sales of products derived from intellectual property acquired as part of the Acquired Assets.
(jj) "Parties" shall mean Assignor, Assignee, and the Major Stockholders, each of which or whom is sometimes referred to as a "Party."
(kk) "Patent Rights" shall mean the United
States and foreign patents and patent applications listed in
Section 1.1(jj) of the Disclosure Schedule.
(ll) The term "person" shall mean an individual, corporation, partnership, limited partnership, limited liability company, unincorporated association, trust, joint venture, union or other organization or entity, including a Governmental Authority.
(mm) "Premises" shall mean Assignor's leased premises located at 100 Delawanna Avenue, Suite 200, Clifton, NJ 07014.
(nn) "Principal Supplier" shall mean Axis Sp., a corporation incorporated under the laws of Poland.
(oo) "Records" shall mean and include all of the following to the extent that they relate to any Acquired Asset (in each case, whether such materials are evidenced in writing, electronically, or otherwise): all business records (including regulatory compliance records); all Regulatory Correspondence (together with all supporting and background documentation); submissions and reports to any notified body or competent authority and all other records and materials necessary to comply with requirements of third party auditors; all data and information relating to any testing of Acquired Assets; risk management records; documents, correspondence, studies, reports, and all other books, ledgers, files, and records of every kind; tangible data; any vendor, supplier or service provider lists (including a description of the underlying commercial arrangements with such vendors, suppliers or service providers that may omit the financial terms); promotional literature and advertising materials with support data; catalogs; research material; technical information, blueprints, technology, technical designs, drawings, specifications and other product development records used or held for use by or on behalf of Assignor or any Assignor Affiliate.
(pp) "Regulatory Correspondence" shall mean any and all of the following: all applications, registrations, approvals, concurrences, and filings with, and other submissions and correspondence relating to any Acquired Asset, including to or from a United States or foreign patent office, any state counterpart, and any other Governmental Authority (in each case together with all supporting and background documentation).
(qq) "Related Documents" shall mean (i) each of this Agreement, the Supply and Distribution Agreement, the Escrow Agreement and the instruments of transfer contemplated by Section 3.3 and (ii) each other document to which Assignor or any of the
Assignor Affiliates or Assignee or a Major Stockholder or any of their respective Affiliates is a party that is delivered in connection with the transactions contemplated by this Agreement.
(rr) "Security Deposits" shall mean those security deposits made by Assignor in respect of the Lease.
(ss) "Subject IP" shall mean all rights in any
and all of the following throughout the world: (i) inventions,
processes, methods, compounds, designs, formulas, know-how;
(ii) Subject Patent Rights, (iii) Copyrights, (iv) Trademarks,
(v) Trade Secrets and (vi) rights to sue, recover and retain damages
for past, present and future infringement, misappropriation, dilution,
or other violation of any of the foregoing, used or held for use by
Assignor or any Assignor Affiliate in connection with any Acquired
Asset or the Exploitation of any Acquired Asset.
(tt) "Subject Patent Rights" shall mean all Patent Rights that are licensed to or otherwise available to Assignor or any Assignor Affiliate and used or held for use by Assignor or any Assignor Affiliate in connection with any Acquired Asset or the Exploitation of any Acquired Asset.
(uu) "Tax" or "Taxes" shall mean any federal, state, local, or foreign income, single business, gross receipts, sales, license, payroll, employment, excise, severance, stamp, occupation, premium, windfall profits, environmental (including Taxes under Code Section 59A), customs duties, capital stock, franchise, profits, withholding, social security (or similar), unemployment, disability, real property, personal property, sales, use, transfer, registration, value added, alternative or add-on minimum, estimated, or other Tax of any kind whatsoever, whether computed on a separate or consolidated, unitary or combined basis or in any other manner, including any interest, penalty, or addition thereto, whether disputed or not and including any obligation to indemnify or otherwise assume or succeed to the Tax liability of any other person.
(vv) "Tax Return" shall mean any return, declaration, report, claim for refund, or information return or statement relating to Taxes, including any schedule or attachment thereto, and including any amendment thereof.
(ww) "Trademarks" shall mean all trademarks, service marks, trade dress, logos, slogans, trade names, corporate names, and Internet domain names, together with all translations, adaptations, derivations, and combinations thereof and including all goodwill associated therewith, and all applications, registrations, and renewals in connection therewith, that are owned, used or held for use by Assignor in connection with any Acquired Asset.
(xx) "Trade Secret" shall mean all data and information owned by, used by or held for use by or on behalf of or licensed to (or otherwise available to) Assignor or any Assignor Affiliate and maintained in confidence by Assignor or any Assignor Affiliate, that in any way relates to any Acquired Asset or the Exploitation of any Acquired Asset, including all related processes, plans, designs, research, operating manuals, methods, compounds, formulae, discoveries, developments, designs, drawings, technology, techniques, procedures, know-how, specifications, inventions, customer and supplier lists (including a description of the underlying
commercial arrangements with such customers and suppliers that may omit the financial terms), and other scientific or technical data or information conceived, memorialized, developed or reduced to practice, in each case whether or not patentable in any jurisdiction. Until such time as any particular patent has been published in accordance with the terms of a patent application or such patent application has been published, the term "Trade Secret" shall be deemed to include all inventions disclosed in such patent application.
(yy) "Union Liability" shall mean any liabilities or payment obligations owing to any labor union or under any labor union contract, including without limitation, that certain Collective Bargaining Agreement between Assignor and Local 262 RWDSU, UFCW dated November 6, 2013, and including without limitation any payment obligations to any health and welfare fund relating thereto.
1.2. Other Defined Terms. Definitions of the defined terms listed below are contained in the Section set forth opposite the defined term in the table below:
Defined Term Section of Agreement Acquired Assets Section 2.1 Assignee Preamble Assignee Indemnified Parties Section 9.1(b) Assignor Preamble Assignor Indemnified Parties Section 9.1(a) Assumed Liabilities Section 2.2 Claim Notice Section 9.2(a) Closing Section 3.2 Closing Date Section 3.2 Competitive Activities Section 8(a) Contracts Section 4.4 Damages Section 9.1(a) Escrow Agent Section 3 Escrow Agreement Section 3 Escrow Shares Section 3 Excluded Liabilities Section 2.4 Indemnification Claim Section 9.2(a) Indemnified Party Section 9.2(a) Indemnifying Party Section 9.2(a) Major Stockholders Preamble Material Contracts Section 4.4 Patent Applications Section 4.12 Permits Section 4.9(a) Product Data Section 4.7(a) Protected Entity Section 8(a) Purchase Price Section 3 Securities Section 4.17 Shares Section 4.17 |
Supply and Distribution Agreement Section 6.2(c)
Third-Party Claim Section 9.2(a)
2. Purchase of the Acquired Assets.
2.1. Purchase and Sale. Upon the terms and subject to the conditions of this Agreement, at the Closing, Assignor shall sell, transfer and assign to Assignee, and Assignee shall purchase and acquire from Assignor, all right, title and interest throughout the world in and to all of the assets of Assignor (but not including any Excluded Assets), as they exist on the Closing Date (the "Acquired Assets"), in each case free and clear of all Liens and Liabilities, including without limitation:
(a) the tangible assets relating to the Balance and Scale Business, including without limitation, Inventory, machinery, jigs, tools, dies, furnishings, computers, fixtures and equipment;
(b) the intangible assets relating to the Balance and Scale Business, including without limitation, all technology, licenses, patents, trademarks, trade names, in process research and development, customer lists;
(c) to the extent transferable, all Permits, if any;
(d) to the extent the following relate to any Acquired Asset: all claims, causes of action, chooses in action, rights of recovery, and rights of set-off of any kind;
(e) all rights under Assumed Contracts;
(f) to the extent that any of the following relate primarily to an Acquired Asset: all other assets of Assignor (whether real, personal or mixed, tangible or intangible);
(g) all goodwill and moral rights relating to any Acquired Asset; and
(h) Assignor's website operated under the domain name "www.torbalscales.com" and all other domain names owned by Assignor or a Major Stockholder, including without limitation those set forth on Schedule 2.1(h) of the Disclosure Schedule;
(i) the telephone numbers used by Assignor in connection with the Balance and Scale Business set forth on Schedule 2.1(i) of the Disclosure Schedule;
(j) all other assets of Assignor including its Inventory related to the Balance and Scale Business, systems and methods owned or under development by or on behalf of Assignor.
2.2. Assumption of Liabilities. Effective as of the Closing Date, Assignee shall assume and agree to perform the Assumed Liabilities, as set forth in this Section 2.2.
Assignee shall be responsible for payment and performance of, and agrees to pay and perform, and be solely responsible for all of (and Assignor shall have no responsibility with respect to) the Assumed Liabilities. The "Assumed Liabilities" shall mean all liabilities of Assignor arising under the Assumed Contracts from and after the Closing (other than liabilities or obligations (i) attributable to any failure by Assignor to comply with the terms of any Assumed Contract prior to Closing or (ii) which both (x) are not apparent on the face of any Assumed Contract and (y) were not disclosed to Assignee in the Disclosure Schedule). Other than as may be required under the Assumed Contracts, Assignor agrees to assume and pay and Assignee shall have no responsibilities with respect to the outstanding obligations under or with respect to any liens or encumbrances as of the Closing Date related to the Acquired Assets.
2.3. Excluded Assets. Nothing herein shall be deemed to sell, transfer, assign or convey to Assignee, Assignor's right, title and interest as of the Closing Date in and to the Excluded Assets.
2.4. Excluded Liabilities. Assignor shall be responsible for payment and performance of, and agrees to pay and perform, and be solely responsible for all (and Assignee shall not have any responsibility with respect to any) liabilities and obligations of Assignor other than the Assumed Liabilities (the "Excluded Liabilities"), including any Union Liability (estimated to be approximately $59,000) and all liabilities and obligations in any way relating to any Acquired Asset (including without limitation liabilities owing in respect of utilities, telephones, leases, and other services) on or prior to the Closing Date. Notwithstanding the foregoing, Assignee agrees that it shall reimburse Assignor for Assignee's monthly payments under the Lease (up to $5,700 per month) for the period from the Closing Date through June 30, 2014 and, thereafter, shall pay half (50%) of the costs of terminating the Lease as of June 30, 2014 (up to a maximum amount of $27,800 representing 3.5 months of rent under the Lease).
3. Purchase Price and Closing.
3.1. Purchase Price. Subject to the other provisions of this Agreement, Assignee shall pay to Assignor, the purchase price (the "Purchase Price") as follows:
(a) at Closing:
(i) $430,000 by wire transfer of immediate funds to the account designed by Assignor;
(ii) Such number of restricted shares of Common Stock of Assignee registered in the name of Assignor with an aggregate value equal to the adjusted Shares value determined in accordance with Section 3.1(c) below (the "Shares") based on a per share value equal to the weighted average of the closing sale prices for shares of Assignee Common Stock on the OTCQB Market of the OTC Markets Group (OTCQB: SCND) (or such other market or national quotation bureau on which Assignee's Common Stock is traded or quoted) for the last five trades effected prior to the Closing (which as of close of business on February 25, 2014 was determined to be $3.38 per Share resulting in 126,449 Shares to be issued at the Closing subject to recalculation in the event of any additional trades or sales of Inventory prior to Closing). Seventy-five percent (75%) of the Shares shall be issued and delivered to Assignor as
soon as practicable but no
later than three (3) business days following the Closing Date, and
subject to the terms of the Escrow Agreement, the remaining T
wenty-Five percent (25%) of the Shares shall be issued on the
Closing Date and delivered to the Escrow Agent, for release and
distribution by the Escrow Agent in accordance with the Escrow
Agreement on the first anniversary of the Closing Date.
(b) The following amounts by wire transfer of immediate funds to the account designated by Assignor:
(i) 8% of Net Sales during the period from the Closing Date to June 30, 2014, annualized;
(ii) 9% of Net Sales for the year ending June 30, 2015;
(iii) 10% of Net Sales for the year ending June 30, 2016; and
(iv) 11% of Net Sales for the year ending June 30, 2017.
Such payments shall be made by Assignee within ninety (90) days following the end of each measurement period and shall be accompanied by a notice setting forth the supporting detail for the calculation signed by an officer of Assignee.
(c) The $500,000 aggregate value of the Shares to be delivered at the Closing pursuant to Section 3.1(a)(ii) above shall be reduced by the amount equal to 50% of the amount by which the June 2013 Inventory Value exceeds the Closing Inventory Value (which as of February 25, 2014 was calculated to result in a net reduction of $72,500 (representing ($289,000-$144,000)/2) resulting in an aggregate value of the Shares being $427,500.
3.2. Closing. The closing of the purchase and sale of the Acquired Assets (the "Closing") shall be held at 10:00 a.m. at the offices of Reitler Kailas & Rosenblatt LLC, 885 Third Avenue, 20th Floor, New York, NY 10022 (or remotely via exchange of documents and signature pages including via PDF and facsimile) on February 26, 2014 or such other date as the Parties may agree (the "Closing Date"). The Parties agree to use reasonable best efforts to effect the Closing on or prior to February 28, 2014.
3.3. Instruments of Transfer. The transfer of the Acquired Assets to Assignee and the assumption of Assumed Liabilities by Assignee at the Closing shall be effected by the execution and delivery of one or more bills of sale and assignment and other instruments of transfer or assumption, all in forms prepared by Assignee and reasonably acceptable to Assignor.
3.4. Purchase Price Allocation. Assignee shall prepare an allocation of the Purchase Price and Assumed Liabilities (and all other capitalized costs) among the Acquired Assets in accordance with Code Section 1060, which allocation is subject to Assignor's approval or disapproval, it being understood that both Assignor and Assignee must agree to the allocation. Assignee shall deliver such allocations to Assignor within sixty (60) days after the Closing Date. Assignee and Assignor shall report and file Tax Returns (including IRS Form 8594) in all respects and for all purposes consistent with such allocation as prepared by Assignee. Assignor
shall timely
and properly prepare, execute, file and deliver all such documents and
other information as Assignee may reasonably request to prepare such
allocation
4. Representations and Warranties of Assignor. As a material inducement to Assignee to enter into this Agreement and each of the other Related Documents to which it is a party, Assignor and the Major Stockholders, jointly and severally, represent and warrant to Assignee that, except as set forth in the Disclosure Schedule, the following statements are true and correct as of the Closing Date:
4.1. Due Organization; Qualified; No Subsidiaries. Assignor is a corporation duly organized, validly existing and in good standing under the laws of New Jersey. Assignor has corporate power to own its properties and to conduct its business as currently owned and conducted. Assignor does not have and has not had any subsidiaries and does not own and has not owned any equity interest in any other corporation or entity.
4.2. Authorization. Assignor has the full legal right, power and authority to enter into and perform the transactions contemplated by this Agreement and the other Related Documents to which it is a party, without need for any registration, qualification, consent, approval, authorization, license or order of, or notice to or filing with any Governmental Authority or other person. The execution, delivery and performance by Assignor of this Agreement and the other Related Documents to which it is a party and the consummation by Assignor of the transactions contemplated hereby and thereby have been duly and validly authorized and approved by all necessary corporate action of Assignor, including approval of this Agreement and the other Related Documents to which Assignor is a party by the Board of Directors and the holders of at least the percentage of shares of capital stock of Assignor required to approve the transactions required to approve the transactions contemplated hereby and thereby. This Agreement and the other Related Documents to which Assignor is a party evidence the legal, valid and binding obligations of Assignor, enforceable against Assignor in accordance with their respective terms, subject to bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium or similar Law relating to or affecting the rights and remedies of creditors generally. This Agreement and the other Related Documents to which Assignor is a party have been duly and validly executed and delivered by Assignor.
4.3. No Conflicts or Violation. The execution, delivery and performance by Assignor of this Agreement and the other Related Documents to which it is a party do not and will not violate or require any registration, qualification, consent, approval, authorization, license or order of, or notice to or filing under any Law by which Assignor or any of its assets or properties may be bound or conflict with, require any registration, qualification, consent, approval, authorization, license or order of, or notice to or filing under, or result in the breach or termination of any provision of, constitute a default under, result in the acceleration of the performance of Assignor's obligations under, result in the loss of Assignor's rights under, result in the vesting or enhancement of any other person's rights under or result in the creation of any Lien upon any of the Acquired Assets or businesses pursuant to (i) the certificate of incorporation, as amended, or by-laws of Assignor or any of its Affiliates or any shareholders' agreement that directly or indirectly is of relevance to the operation of Assignor, (ii) any Material Contract or Assumed Contract or (iii) any indenture, mortgage, deed of trust, license, permit, approval, consent, franchise, lease or other Contract to which Assignor is a party or by which
Assignor or any of Assignor's assets is bound (in all of the foregoing cases whether with or without notice, lapse of time, or both, or the happening or the occurrence of any other event).
4.4. Contracts and Commitments. Section 4.4 of the Disclosure Schedule lists each of the following agreements, understandings, arrangements or commitments ("Contracts"), to the extent such Contract relates to any Acquired Asset:
(a) All Contracts between Assignor and any Affiliate(s) of any Insider or any member of any Insider's family;
(b) All purchase orders and contracts of Assignor outstanding as of the date of this Agreement;
(c) All Contracts relating to research and development conducted or to be conducted by or on behalf of Assignor;
(d) All confidentiality and nondisclosure Contracts, assignment of rights or inventions Contracts and non- competition Contracts and covenants under which Assignor or, any Assignor Affiliate that has been, is or will be engaged in the Exploitation of any Acquired Asset, is obligated and any Contract restricting Assignor or any Assignor Affiliate from Exploiting any Acquired Asset anywhere in the world;
(e) All Contracts relating to Liens on the Acquired Assets;
(f) All loan Contracts or other Contracts relating to debt obligations for borrowed money, all guarantees of or Contracts to acquire debt obligations of any person and all Contracts relating to loans made by Assignor to any person, including all Contracts relating to Liens intended to secure any such loan, debt obligation or guarantee; and
(g) All other Contracts of Assignor that affect any Acquired Asset that are not otherwise disclosed herein, including without limitation, the Lease.
For purposes of this Agreement, each Contract listed in Section
4.4 of the Disclosure Schedule shall be a "Material Contract."
Section 4.4 of the Disclosure Schedule also sets forth a description
of all negotiations currently in process or contemplated that
relate to any Material Contract.
4.5. Material Contracts; No Default; Assumed Contracts and Commitments; No Default.
(a) Assignor has delivered to Assignee true, correct and complete copies of all Material Contracts and all Assumed Contracts.
(b) All Material Contracts and Assumed Contracts are valid and in full force and effect, enforceable against and by Assignor in accordance with their respective terms, subject to bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium or similar Law relating to or affecting the rights and remedies of creditors generally.
(c) All Material Contracts and Assumed Contracts were entered into by Assignor in the normal, usual and ordinary course of business and no other party thereto has asserted any right of defense, setoff or counterclaim with respect to any amount due or becoming due thereunder to Assignee after the Closing arising from events which precede the Closing Date.
(d) Assignor is not in default in the performance of any of its obligations under any Material Contract or Assumed Contract; no default has occurred which (whether with or without notice, lapse of time, or both, or the happening or the occurrence of any other event) would constitute an event of default by Assignor under any Material Contract or Assumed Contract; no other party thereto is in default under any Material Contract or Assumed Contract; and there has not occurred any event or condition which (whether with or without notice, lapse of time, or both, or the happening or the occurrence of any other event) constitutes a basis of force majeure or other claim of excusable delay or nonperformance by any person under any Material Contract or Assumed Contract. No notice has been received by Assignor claiming any default by Assignor under any Material Contract or Assumed Contract or indicating the intention of any other party thereto to amend, modify, rescind, terminate or default under any Material Contract or Assumed Contract, and Assignor is not aware of any threat thereof or basis therefore, and Assignor has not waived any material right under or with respect to any Material Contract or Assumed Contract.
4.6. Title to the Acquired Assets. Assignor has the full right to sell, transfer, and assign all of the Acquired Assets to Assignee, and has good and marketable title thereto, free and clear of all Liens. Following the Closing, Assignee will be the lawful owner of, and have good title to, the Acquired Assets, free and clear of all Liens. None of the Acquired Assets is in the possession, custody or control of any person other than Assignor.
4.7. Matters Relating to the Acquired Assets.
(a) Section 4.7(a) of the Disclosure Schedule provides a true, correct and complete list of the following (the "Product Data"):
(i) All locations at which Acquired Assets are located as of the Closing Date (including locations owned or controlled by third parties); and
(ii) A "purchase item file', including names and addresses of all suppliers and subcontractors for all items currently used in connection with any Acquired Asset.
(b) No officer, director, employee or stockholder of Assignor has any proprietary interest in a product, system, method or process constituting all or any portion of an Acquired Asset.
(c) Section 4.7 of the Disclosure Schedule sets forth an on-hand report for the Inventory and a completion report for the works-in progress comprising part of the Inventory. Except as set forth therein, the Inventory is free and clear of all Liens and encumbrances, and in mint and salable condition.
4.8. Litigation; Other Claims. There is no claim, action, suit, proceeding, arbitration, complaint, charge or investigation pending or to Assignor's knowledge, currently threatened (i) against Assignor or any officer, director or employee of Assignor arising out of their relationship with Assignor; or (ii) that questions the validity of the transactions contemplated by this Agreement; or (iii) to Assignor's knowledge, that would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. Neither Assignor nor, to Assignor's knowledge, any of its officers, directors or employees is a party or is named as subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality (in the case of officers, directors or employees, such as would affect Assignor). There is no action, suit, proceeding or investigation by Assignor pending or which Assignor intends to initiate.
4.9. Licenses and Permits; Regulatory Filings; Legal Compliance.
(a) Section 4.9(a) of the Disclosure Schedule provides a true, correct and complete list of:
(i) all licenses (including without limitation export control licenses), permits, orders, franchises, certificates, and other governmental authorizations, consents, rights, concurrences, registrations and approvals required by any Governmental Authority that are specifically related to any Acquired Asset (collectively, the "Permits"); and
(ii) to the extent not listed pursuant to
Section 4.9(a)(i), all Regulatory Correspondence of Assignor related to
the Acquired Assets.
(b) Assignor has obtained and maintains all the Permits in accordance with applicable law and regulation. All the Permits are valid and in full force and effect and all information submitted to the applicable Governmental Authority in order to obtain each such Permit was true, accurate and complete when submitted, and there is no impediment to any renewal thereof. Assignor and its Affiliates are in compliance with the respective requirements, conditions and provisions of all Permits and neither Assignor, nor any Assignor Affiliate has been informed by any Governmental Authority or any lawyer or consultant of Assignor or any Assignor Affiliate of any deficiency with respect to any Permit. No proceeding is pending or, to the Knowledge of Assignor or any Assignor Affiliate, threatened to revoke or amend any of such Permits nor are there facts or circumstances of which Assignor or any Assignor Affiliate is aware which form a basis upon which a Governmental Authority reasonably could seek to revoke or amend any Permit. The execution and delivery of this Agreement and the consummation of the transactions contemplated by this Agreement will not result in a modification, impairment, revocation, suspension or limitation of any Permit. No Permit by its terms requires the consent of its issuing authority in order to remain in full force and effect after the execution and delivery of this Agreement or the consummation of the transactions contemplated by this Agreement.
4.10. Conduct of Business in Compliance with Regulatory Requirements; Warranties.
(a) Assignor is in compliance with all Law applicable to any Acquired Asset or the Exploitation of any Acquired Asset. Since January 1, 2008, neither Assignor, nor any Assignor Affiliate has been restrained in the Exploitation of any Acquired Asset or Assignor Product.
(b) Neither Assignor nor any Assignor Affiliate has made any false statement in, or material omission from, the applications, approvals, reports, or other submissions to the United States Patent Office, foreign patent office or other Governmental Authorities.
(c) Neither Assignor, nor any Assignor Affiliate has made any false statement in, or material omission from, any report, study or other documentation prepared in conjunction with the applications, approvals, reports, or records submitted to or prepared for the United States Patent Office, foreign patent office or other Governmental Authorities relating to any Acquired Asset.
(d) Neither Assignor nor any Assignor Affiliate has made or offered any payment, gratuity, or other thing of value that is prohibited by any Law to personnel of the United States Patent Office, foreign patent office or other Governmental Authorities in connection with the approval of any patent application related to an Acquired Asset.
4.11. Subject IP.
(a) Misappropriation; Non-Infringement. Assignor
owns or possesses or can acquire on commercially reasonable terms
sufficient legal rights to all of the Subject IP without any conflict
with, or infringement of, the rights of others. No product or service
marketed or sold (or proposed to be marketed or sold) by Assignor
violates any license or infringes any intellectual property rights
of any other party. Other than with respect to commercially available
software products under standard end-user object code license
agreements, there are no outstanding options, licenses, agreements,
claims, encumbrances or shared ownership interests of any kind
relating to the Subject IP, nor is Assignor bound by or a party
to any options, licenses or agreements of any kind with respect to
the patents, trademarks, service marks, trade names, copyrights,
trade secrets, licenses, information, proprietary rights or
processes of any other Person. Assignor has not received any
communications alleging that Assignor has violated or, by conducting
its business, would violate any of the patents, trademarks, service
marks, tradenames, copyrights, trade secrets, mask works or other
proprietary rights or processes of any other Person and, to the
Knowledge of Assignor, there is no threat thereof or basis therefor.
Assignor has obtained and possesses valid licenses to use all
of the software programs present on the computers and other
software-enabled electronic devices that it owns or leases or
that it has otherwise provided to its employees for their use in
connection with the Balance and Scale Business. It will not be
necessary to use any inventions of any of its employees or
consultants made prior to their employment by Assignor. Each
employee and consultant of Assignor has assigned to Assignor all
intellectual property rights he or she owns that are related to
the Subject IP or the Balance and Scale Business as conducted by
Assignor. Subject IP includes, without limitation, those items
listed on Section 4.11 of the Disclosure Schedule. Assignor has
not embedded any open source, copyleft or community source code
in any of its products generally available or in development,
including but not
limited to any libraries or code licensed under any General Public License, Lesser General Public License or similar license arrangement. Assignor has not misappropriated any patent, invention, process, method, compound, design, formula or other proprietary or intellectual property rights of any third person that are incorporated in the Subject IP or in any way relate to the Balance and Scale Business or the Acquired Assets. There are no rights owned by Assignor or an Assignor Affiliate or any other person that would prevent the Exploitation of any Acquired Asset within its terms.
4.12. Trade Secrets. Assignor is the sole owner of all Trade Secrets, free and clear of all Liens. Assignor has not misappropriated any of the Trade Secrets. Neither Assignor nor any Assignor Affiliate, nor to Assignor's Knowledge, any other person, has taken or omitted to take any action that has made or may make the Trade Secrets part of public knowledge or literature, or used, divulged, or appropriated the Trade Secrets for the benefit of any person other than Assignor or to the detriment of Assignor. Assignor has taken reasonable steps to protect the confidentiality of all Trade Secrets, including entering into confidentiality and assignment agreements with all Assignor Affiliates having access to Confidential Information relating to any Acquired Asset and prohibiting them from disclosing such information or using the same for their own benefit, for the benefit of any person other than Assignor or to the detriment of Assignor. To the Knowledge of Assignor, no person is in breach of any such confidentiality and assignment agreement in any respect that could negatively affect the Subject IP, Subject License or Subject Sublicenses or Assignor's or Assignee's rights therein.
4.13. Financial Statements. Assignor has delivered to
Assignee the unaudited balance sheets of Assignor as of
June 30, 2013 and November 30, 2013 and its unaudited
financial statements (including balance sheet, income
statement and statement of cash flows) for the 12-month
period ended June 30, 2013 and for the five-month period
ended November 30, 2013, including the notes thereto
certified by Assignor's chief financial officer (collectively,
the "Financial Statements"). Such Financial Statements
fairly present the financial condition and the results of
operations, of Assignor as of the dates of and for the
periods referred to in such Financial Statements, all in
accordance with GAAP, subject to normal year-end adjustments.
The Financial Statements reflect the consistent application
of such accounting principles throughout the period involved,
except as disclosed in the notes to such Financial Statements.
Since June 30, 2013, there has not been any change in the
assets, liabilities, financial condition or operating results
of Assignor from that reflected in the Financial Statements,
except changes in the ordinary course of business that have
not caused, in the aggregate, a material adverse effect on
the financial condition, business, operations or prospects of
Assignor. Except as set forth in the Financial Statements,
Assignor has no material liabilities or obligations, contingent
or otherwise, other than (i) liabilities incurred in the
ordinary course of business, (ii) obligations under contracts
and commitments incurred in the ordinary course of business and
(iii) liabilities and obligations of a type or nature not
required under GAAP to be reflected in the Financial Statements,
which, in all such cases, individually and in the aggregate
would not have a Material Adverse Effect. Assignor has no
liabilities of any nature (matured or unmatured, accrued, fixed
or contingent), which have had, or have a reasonable probability
of having, a Material Adverse Effect.
4.14. Taxes. Assignor is a "C" corporation and has timely filed or will have timely filed all Tax returns for the periods or portions thereof ending on or prior to the Closing
Date that are required to be filed on or prior to the Closing Date with any Taxing authority, and all such Tax returns are true, accurate and complete in all respects. Assignor has timely paid, or made adequate provision for the payment of, all Taxes shown to be due on such Tax returns, all Tax assessments received, and all Taxes that have or may become due under applicable law with respect to all periods or portions thereof ending on or prior to the Closing Date. There are no liens for Taxes on any of the Acquired Assets. Assignor has not received notice of any claim for assessment or collection of Taxes and no such claim is pending or is, to the Knowledge of Assignor, presently being asserted against Assignor or with respect to any of the Acquired Assets. Assignor is not a party to any pending audit, investigation, action or proceeding with any Taxing authority, nor does Assignor have Knowledge of any threatened audit, investigation, action or proceeding by any Taxing authority with respect to Assignor or any of the Acquired Assets. Assignor has not received written notice of any claim by any Taxing authority in any jurisdiction where it does not file Tax returns or pay Taxes that it is or may be subject to Tax by that jurisdiction. Assignor has timely withheld and timely paid all Taxes that are required to have been withheld and paid by Assignor in connection with amounts paid or owing to any employee, independent contractor, creditor or other person. Assignor not a party to or bound by any Tax sharing agreement, Tax allocation agreement, or Tax indemnity agreement. Assignor is not presently liable, nor does Assignor have any potential liability, for the Taxes of another Person under applicable Tax law, as transferee or successor, or by contract, indemnity or otherwise.
4.15. Environmental Matters. Assignor is in compliance with applicable Environmental Law. Neither Assignor, nor, to Assignor?s Knowledge, any prior owner, user, controller, or occupant, nor any tenant, subtenant, prior tenant, or prior subtenant has ever used Hazardous Substances on, from, or affecting the Acquired Assets or any facility, site, area, or property owned, used, controlled, or occupied by Assignor in any manner that violates any Federal, state, or local law, regulation, governmental restriction, order, judgment, or decree governing the use, storage, treatment, transportation, manufacture, handling, production, or disposal of Hazardous Substances.
4.16. Changes. Except as set forth in Schedule 4.16, since June 30, 2013 there has not been:
(a) any change in the assets, liabilities, financial condition or operating results of Assignor from that reflected in the Financial Statements, except changes in the ordinary course of business that have not caused, in the aggregate, a Material Adverse Effect;
(b) any damage, destruction or loss, whether or not covered by insurance, that would have a Material Adverse Effect;
(c) any waiver or compromise by Assignor of a valuable right or of a material debt owed to it;
(d) any satisfaction or discharge of any lien, claim, or encumbrance or payment of any obligation by Assignor, except in the ordinary course of business and the satisfaction or discharge of which would not have a Material Adverse Effect;
(e) any material change to a material contract or agreement by which Assignor or any of its assets is bound or subject;
(f) any material change in any compensation arrangement or agreement with any employee, officer, director or stockholder;
(g) any resignation or termination of employment of any officer or key employee of Assignor;
(h) any mortgage, pledge, transfer of a security interest in, or lien, created by Assignor, with respect to any of its material properties or assets, except liens for taxes not yet due or payable and liens that arise in the ordinary course of business and do not materially impair Assignor's ownership or use of such property or assets;
(i) any loans or guarantees made by Assignor to or for the benefit of its employees, officers or directors, or any members of their immediate families, other than travel advances and other advances made in the ordinary course of its business;
(j) any declaration, setting aside or payment or other distribution in respect of any of Assignor's capital stock, or any direct or indirect redemption, purchase, or other acquisition of any of such stock by Assignor;
(k) any sale, assignment or transfer of any Assignor Intellectual Property;
(l) receipt of notice that there has been a loss of, or material order cancellation by, any major customer of Assignor;
(m) to Assignor's knowledge, any other event or condition of any character, other than events affecting the economy or Assignor?s industry generally, that could reasonably be expected to result in a Material Adverse Effect; or
(n) any arrangement or commitment by Assignor to do any of the things described in this Subsection 4.15.
4.17. Investment Representations. Assignor is an "accredited investor" as such term is defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933, as amended (the "Securities Act"). Assignor is acquiring the Shares for its own account and has and will have on the Closing Date no current arrangements or understandings for the resale or distribution of the Shares to others in violation of applicable Law and will only resell the Shares or any portion thereof pursuant to an effective registration statement or an available exemption under applicable Law. Assignor does not presently have any contract, undertaking, agreement or arrangement with any person or entity to sell, transfer or grant participation to such person or entity or to any third person or entity with respect to any of the Shares or interest in any of the foregoing securities. Assignor acknowledges that the offer and sale of the Shares have not been
registered under the Securities Act or the securities Laws of any state or other jurisdiction, and that the Shares are being offered and sold pursuant to an exemption from registration contained in the Securities Act, the availability of which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of Assignor's representations as expressed herein or otherwise made pursuant hereto, and the Shares cannot be disposed of unless they are subsequently registered under the Securities Act and applicable state laws or an exemption from such registration is available. Assignor understands and agrees that the Shares will bear a legend substantially similar to the legend set forth below in addition to any other legend that may be required by applicable Law, the certificate of incorporation or by-laws of SI, as the same may be amended from time to time, the Escrow Agreement or by any other agreement between Assignee and Assignor:
"THE SHARES REPRESENTED BY THIS CERTIFICATE
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND MAY NOT BE TRANSFERRED, SOLD, PLEDGED OR HYPOTHECATED EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND APPLICABLE STATE SECURITIES LAWS, OR (B) THE COMPANY RECEIVES AN OPINION OF COUNSEL QUALIFIED IN SUCH MATTER OR OTHER EVIDENCE REASONABLY SATISFACTORY TO THE COMPANY AND ITS COUNSEL THAT THE PROPOSED TRANSACTION IS EXEMPT FROM REGISTRATION UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS."
4.18. Brokerage. There has been no intermediary or broker in negotiations or discussions incident to the execution of this Agreement or any of the transactions contemplated hereby on behalf of Assignor or any Assignor Affiliate. Assignee shall not be responsible for, and Assignor hereby indemnifies Assignee against, any commission or other compensation due or becoming due with respect to any such transactions as a result of the engagement of any such person by Assignor or any Assignor Affiliate.
4.19. Disclosure. The representations and warranties contained in this Section 4, when considered as a whole, do not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements and information contained in this Section 4 not misleading.
5. Representations and Warranties of Assignee. As a material inducement to Assignor to enter into this Agreement and each of the other Related Documents to which it is a party, Assignee hereby represents and warrants to Assignor that the following statements are true and correct as of the date of this Agreement, and shall be true and correct on the Closing Date:
5.1. Due Organization. Assignee is a corporation duly organized, validly existing and in good standing under the laws of Delaware. Each has corporate power to own its
properties and to conduct its businesses as currently owned and conducted and to execute, deliver and perform this Agreement.
5.2. Authorization; Binding Obligations. Assignee has the full legal right, power and authority to enter into and perform the transactions contemplated by this Agreement and the other Related Documents to which it is a party, without need for any registration, qualification, consent, approval, authorization, license or order of, or notice to or filing with any Governmental Authority or other person. The execution, delivery and performance by Assignee of this Agreement and the other Related Documents to which it is a party and the consummation by Assignee of the transactions contemplated hereby and thereby have been duly and validly authorized and approved by all necessary corporate action of Assignee. This Agreement and the other Related Documents to which Assignee is a party evidence the legal, valid and binding obligations of such party, enforceable against it in accordance with their respective terms, subject to bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium or similar Law relating to or affecting the rights and remedies of creditors generally. This Agreement and each other Related Document to which Assignee is a party have been duly and validly executed and delivered by Assignee.
5.3. No Default or Violation. The execution, delivery and performance by Assignee of this Agreement and the other Related Documents to which it is a party and the consummation by Assignee of the transactions contemplated hereby and thereby do not, and will not (whether with or without notice, lapse of time, or both, or the happening or the occurrence of any other event), conflict with any provision of the certificate of incorporation or bylaws of Assignee, and do not, and will not (whether with or without notice, lapse of time, or both, or the happening or the occurrence of any other event), violate any Law to which Assignee or any of its properties is subject.
5.4. Securities Filings. Assignee has filed all forms, reports, statements and documents required to be filed with the Securities and Exchange Commission (the "SEC") since June 30, 2013, each of which has complied in all material respects with the applicable requirements of the Securities Act and the Securities Exchange Act of 1934, as amended, each as in effect on the date so filed (collectively, the "SEC Filed Documents"). The SEC Filed Documents are available on the SEC's website at www.sec.gov. As of their respective dates, or as of the date of the last amendment thereof, if amended after filing, none of the SEC Filed Documents contained a material fact or omitted or to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.
5.5. Brokerage. There has been no intermediary or broker in negotiations or discussions incident to the execution of this Agreement or any of the transactions contemplated hereby on behalf of Assignee. ssignor shall not be responsible for, and Assignee agrees to indemnify Assignor against, any commission or other compensation due or becoming due with respect to any such transactions as a result of the engagement of any such person by Assignee.
5.6. Valid Issuance of Shares. The Shares, when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement, will be validly issued, fully-paid and nonassessable and free of restrictions on
transfer other than restrictions on transfer under the
Escrow Agreement and applicable state and federal
securities laws and liens or encumbrances created by or
imposed by Assignor. Assuming the accuracy of the
representations and warranties of Assignor contained in
Section 4.17 of this Agreement, the offer, sale and
issuance of the Shares will be exempt from the
registration requirements of the Securities Act of
1933, as amended (the "Securities Act").
5.7. Funding for Marketing and Sales. In recognition of the Purchase Price terms set forth in Section 3.1(b), from the Closing Date until June 30, 2017, Assignee agrees to use reasonable commercial efforts to commit approximately the same levels of marketing and sales funding in support of the Balance and Scale Business as such levels existed for the 12 months immediately preceding the Closing Date, in each case as determined and allocated by Assignee?s Board with input from Karl Nowosielski.
6. Conditions Precedent to Closing
6.1. Conditions to Each Party's Obligations under this Agreement. The respective obligations of each Party under this Agreement shall be subject to the fulfillment as of the Closing of the following conditions:
(a) Injunctions. No Party hereto shall be subject to any order, decree or injunction of a court or agency of competent jurisdiction which enjoins or prohibits the consummation of any of the transactions contemplated by this Agreement and the other Related Documents;
(b) Approvals and Authorizations. All necessary registrations, qualifications, consents, approvals, authorizations, licenses or orders of all Governmental Authorities required to consummate the transactions contemplated by this Agreement and the other Related Documents shall have been obtained and shall remain in full force and effect and all waiting periods relating to such registrations, qualifications, consents, approvals, authorizations, licenses or orders shall have expired; and
(c) Litigation. There shall not be any pending or threatened Litigation Matter that shall seek to restrain, prohibit or invalidate any of the transactions contemplated by this Agreement and the other Related Documents.
6.2. Conditions to Obligations of Assignee. The obligations of Assignee to complete the transactions to be consummated at the Closing are subject to the satisfaction as of the Closing of all of the following conditions (or the waiver thereof by Assignee):
(a) Each of the representations and warranties of Assignor in this Agreement shall be true and correct as of the Closing Date (except to the extent such representations and warranties speak as of an earlier date, in which case such representations and warranties shall be true and correct as of such earlier date);
(b) Assignor shall have duly complied with and performed all of the terms, covenants and conditions of this Agreement to be complied with or performed by Assignor at or before the Closing;
(c) The Principal Supplier shall have executed and delivered to Assignee the Supply and Distribution Agreement in the form of Exhibit A hereto, providing for inter alia the agreement of Principal Supplier to produce and deliver through February 28, 2020 exclusively for and to (or on behalf of) Assignee all of its requirements for Balance and Scale products for production or sale in the United States and Canada on an exclusive basis, and non-exclusively in Mexico, Central America and South America.
(d) Karl Nowsielski shall have duly executed and delivered to Assignee the employment agreement between him and Assignee, substantially in the form of Exhibit B hereto.
(e) Each Major Stockholder shall have executed and delivered to Assignee the Non-Competition Agreement in the form of Exhibit C hereto.
(f) Assignor and Assignee shall have agreed on the Closing Inventory Value.
(g) Assignor shall have delivered to Assignee written evidence reasonably satisfactory to Assignee that either (i) the landlord under the Lease has consented to the termination of the Lease effective as of June 30, 2014 for no more than 7 months' rent plus forfeiture by Assignor of its security deposit under the Lease or (ii) Assignor acknowledges its ongoing responsibility under the Lease and can demonstrate its ability to fulfill its obligations thereunder subject to Assignee's reimbursement obligations set forth in Section 2.4 of this Agreement.
(h) Assignor shall have delivered to Assignee written evidence reasonably satisfactory to Assignee that all amounts owing by Assignor to Local 26 RWDSU, UFCW, including under that certain Collective Bargaining Agreement dated November 6, 2011, have been fully paid and no further obligations thereto or thereunder exist.
(i) This Agreement and the Non-Competition A greement shall have been approved by the Board of Directors of Assignor and the requisite owners of the outstanding shares of each class of capital stock of Assignor.
(j) Assignee shall have received the opinion of counsel to Assignor, dated as of the Closing Date, substantially in the form set forth in Exhibit D to this Agreement;
(k) Assignor shall have executed and delivered to Assignee such bills of sale and other instruments of transfer and assignment, including license assignments in recordable form, and such other documents (including any consents thereto by third parties necessary to make the same valid and effective), in such form and containing such terms and provisions as Assignee may reasonably request, as shall be necessary to vest in Assignee all right, title and interest in and to the Acquired Assets free and clear of any and all Liens other than the Assumed Liabilities;
(l) There shall not be any pending or threatened Litigation Matter that shall affect the right of Assignee to own, use or control any Acquired Asset or Assignee's title therein after the Closing Date;
(m) Assignor and the Balance and Scale Business shall not have suffered any Material Adverse Effect (whether or not covered by insurance) nor shall Assignor have suffered the loss or any material adverse change to any Assumed Contract;
(n) Assignor shall have obtained and filed releases with respect to all Liens of record with respect to the Acquired Assets;
(o) Assignor shall have executed and delivered to Assignee each of the Related Documents to which it is a party;
(p) Assignee shall have received from Assignor a certificate, dated as of the Closing Date, executed by the Secretary of Assignor, certifying the incumbency of each person executing this Agreement or any other Related Document on behalf of Assignor, and the authenticity of the Board of Directors and stockholder resolutions authorizing the transactions contemplated by this Agreement and the other Related Documents to which Assignor is a party; and
(q) Assignee shall have received from Assignor a certificate, dated as of the Closing Date, executed by the President of Assignor, certifying that the conditions specified in the preceding clauses of this Section 6.2 have been fulfilled.
6.3. Conditions to Obligations of Assignor. The obligations of Assignor to complete the transactions to be consummated at the Closing are subject to the satisfaction as of the Closing of all of the following conditions (or the waiver thereof by Assignor):
(a) Each of the representations and warranties of Assignee in this Agreement shall be true and correct as of the Closing Date (except to the extent such representations and warranties speak as of an earlier date, with respect to which such representations and warranties shall be true and correct as of such earlier date);
(b) Assignee shall have duly complied with and performed all of the terms, covenants and conditions of this Agreement to be complied with or performed by Assignee at or before the Closing;
(c) Assignee shall have executed and delivered to Assignor the Registration Agreement in the Form of Exhibit E, providing "piggy-back" rights with respect to the Shares;
(d) Assignee shall have executed and delivered to Assignor each of the other Related Documents to which it is a party;
(e) Assignor shall have received from Assignee a certificate, dated as of the Closing Date, executed by an officer of Assignee, certifying that the conditions specified in the preceding clauses of this Section 6.3 have been fulfilled;
(f) Assignor shall have received from Assignee a certificate, dated as of the Closing Date, executed by its Secretary or Assistant Secretary, certifying the incumbency, respectively, of each officer of Assignee executing this Agreement or any other Related Document to which Assignee is a party, and the authenticity of the resolutions authorizing the transactions contemplated by this Agreement and the other Related Documents to which Assignee is a party;
(g) Assignor shall have received the Purchase Price payable or issuable to it at Closing; and
(h) Each Major Stockholder shall have received the consideration set forth in his Non-Competition Agreement ($135,000).
7. Post-Closing Matters.
7.1. Covenant of Further Assurances.
(a) Assignor shall, at any time and from time
to time after the Closing Date, upon the reasonable request of
Assignee, execute, acknowledge, seal and deliver all such
instruments and documents, and do all such further things, as
Assignee may reasonably request to perfect the transfer of any
and all of the Acquired Assets that are to be sold, transferred and
assigned to Assignee under this Agreement or any of the other
Related Documents (including taking any actions necessary to
assure Assignor's proper corporate authorization with respect to
the transactions contemplated by this Agreement and the other
Related Documents) and to deliver or cause to be delivered such
Acquired Assets to Assignee in accordance with the terms of this
Agreement and the other Related Documents. In addition, Assignor
shall use commercially reasonable efforts to obtain for Assignee
all such consents, licenses, permits and approvals as may be
required for Assignor to perform its obligations under this
Agreement or under the other Related Documents or as are necessary
or desirable to accomplish the purchase and sale of the Acquired
Assets or to enable Assignee to fully Exploit any Acquired Asset,
and to provide to Assignee any records or other data relating to
any Acquired Asset which were not previously delivered to Assignee.
(b) Assignor, the Major Stockholders and Assignee shall do or procure to be done all such further acts and things, and execute or procure the execution of all such other documents, as such Party may from time to time reasonably require, whether on or after the Closing, for the purpose of giving to such other Party or Parties the full benefit of all of the provisions of this Agreement and the other Related Documents.
7.2. Payment of Taxes. Assignor shall pay, promptly and when due, whether at the original time fixed therefor or pursuant to any extension of time to pay, any and all Taxes that shall become due or shall have accrued on account of Assignor's ownership of the Acquired Assets, Taxes arising from gains realized by Assignor resulting from any of the transactions contemplated by this Agreement, and Taxes related to the transfer of the Acquired Assets to Assignee.
7.3. Defense of Claims and Litigation. At all times from and after the Closing Date, and without charge except for reimbursement of out-of-pocket expenses, each Party shall consult, confer and cooperate in good faith on a reasonable basis with the other Parties (including the making available of witnesses and cooperation in discovery proceedings) in the conduct or defense of any Litigation Matter against such other Party or Parties or any of its Affiliates by any third person that relates to any Acquired Asset or any Assumed Liability or any matter that, directly or indirectly, arises therefrom, whether known at the Closing Date or arising thereafter. The foregoing notwithstanding, to the extent the indemnification provisions of this Agreement or the provisions of the Registration Agreement apply to any such conduct or defense, they shall control as to the payment of costs and expenses.
7.4. Retention of Records. Assignor agrees
to retain and cause its Affiliates to retain, any material
books, records, documents, instruments, accounts, financial
information, Tax information, production records, employment
records, correspondence, writings, evidences of title and other
papers or information (i) relating to the Acquired Assets as
Assignor possessed or controlled immediately before the
Closing and did not transfer to Assignee hereunder and (ii)
relating to the performance by Assignor of its obligations
under this Agreement and the other Related Documents for seven
(7) years following Closing Date or for such longer period as
may be required by any Law applicable to Assignee or any of its
Affiliates and, in any event, to notify Assignee prior to the
destruction of any of such materials and, upon the request of
Assignee, to turn over to Assignee any of such materials.
7.5. Sharing of Data. Assignee shall have the right for a period of seven (7) years following the Closing Date to have reasonable access to such material books, records, documents, instruments, accounts, financial information, Tax information, production records, employment records, correspondence, writings, evidences of title, and other papers or information to the extent that they relate to (i) the Acquired Assets or (ii) the performance by Assignor of its obligations under this Agreement or the other Related Documents for the limited purposes of complying with applicable Law and defending against a claim or litigation relating to any Acquired Asset. Such access will be subject to the confidentiality obligations of this Agreement.
7.6. Confidentiality.
(a) Obligation. Until the date which is seven (7) years following Closing Date (or, with respect to Trade Secrets, indefinitely), Assignor shall, and shall secure the agreement of its Affiliates, to, keep confidential and not disclose to any third person or use, any Confidential Information relating to any Acquired Asset, that has not previously been made public and any vendor lists, specifications, formulae, know-how, or other proprietary data.
(b) Exceptions. Assignor may disclose Confidential Information to the extent such disclosure is reasonably necessary to prosecute or defend litigation, to comply with applicable Law, to obtain necessary or desirable regulatory approvals, to respond to a valid order of a Governmental Authority, provided that, other than with respect to disclosure for protecting intellectual property rights in which such disclosure is required by applicable Law, Assignor shall (i) use reasonable efforts to secure confidential treatment of such Confidential Information required to be disclosed, and (ii) unless precluded by applicable Law from doing so,
give advance notice to Assignee sufficiently in advance of the proposed disclosure so as to permit Assignee to have the opportunity to object to such disclosure or otherwise protect its Confidential Information.
8. Non-Competition Covenant.
Until a date five years (except with respect to KN for whom the date shall be four years) from the Closing Date, Assignor and each Major Stockholder agree not to, and shall secure the agreements of their respective Affiliates not to, directly or indirectly, participate or engage in the following activities or businesses ("Competitive Activities"): (i) developing or providing products or services which compete with the Balance and Scale Business of Assignee; (ii) soliciting or endeavoring to entice away any person or entity who is or was a customer of Assignee or any of is subsidiaries (collectively, a "Protected Entity") or encouraging any such person or entity to use any products or services which compete with the Balance and Scale Business of Assignee; (iii) assisting any person or entity in any way to do, or attempt to do, anything prohibited by clauses (i) or (ii) above and (iv) directly or indirectly soliciting, recruiting or hiring any person employed by a Protected Entity; provided however this covenant shall not be deemed breached as a result of the ownership by Assignor or any Major Stockholder and their respective Affiliates of less than an aggregate of five (5%) percent of any class of stock of any publicly-traded entity engaged in Competitive Activities.
9. Indemnification Provisions
9.1. Indemnification.
(a) Assignee's Indemnification
Obligations. On and after the Closing Date, Assignee
agrees to indemnify, defend and hold harmless Assignor
and each of its Affiliates, and each of their respective
directors, officers, employees, agents, successors and
assigns (collectively, the "Assignor Indemnified Parties")
from and against and in respect of any and all claims,
losses, damages, costs, expenses, obligations, liabilities,
charges, actions, suits, proceedings, deficiencies, interest,
penalties and fines (including costs of collection, attorney's
fees and other costs of defense, costs of enforcing
indemnification provisions, and expenses of investigation)
(collectively, "Damages") imposed on, sustained, incurred or
suffered by or asserted against any of them, as and when the
same are incurred by any Assignor Indemnified Party, directly
or indirectly, in respect of, but only in respect of:
(i) any breach of Assignee's
representations and warranties contained herein or in any
certificate delivered by Assignee pursuant to the terms of this
Agreement;
(ii) Assignee's failure to perform
or otherwise fulfill any of its agreements, covenants,
obligations or undertakings under this Agreement; and
(iii) the Assumed Liabilities.
Assignee shall not be responsible for any Damages to the extent that such Damages are due to the negligence or willful misconduct of Assignor or an Assignor Affiliate.
(b) Assignor's Indemnification Obligations. On and after the Closing Date, Assignor and each Major Stockholder by this Agreement agrees to jointly and severally indemnify, defend and hold harmless Assignee and each of its Affiliates, and their respective directors, officers, employees, agents, successors and assigns (collectively, the "Assignee Indemnified Parties"), from and against and in respect of any and all Damages imposed on, sustained, incurred or suffered by or asserted against any of them, as and when the same are incurred by any Assignee Indemnified Party, directly or indirectly, but only in respect of:
(i) any breach of Assignor's representations and warranties contained herein or in any certificate delivered by Assignor or a Major Stockholder pursuant to the terms of this Agreement;
(ii) Assignor's or any Major Stockholder's failure to perform or otherwise fulfill any of its agreements, covenants (including without limitation in respect of Tax payment obligations), obligations or undertakings under this Agreement;
(iii) all claims alleging that the Exploitation of any Acquired Asset as such Acquired Asset exists as of the Closing Date infringes any intellectual property right of a third party;
(iv) all Excluded Liabilities (which term includes any Union Liability and all Assignor- Related Claims);
(v) all claims, actions or proceedings, or threatened claims, actions or proceedings, relating to or arising from any of the transactions contemplated by this Agreement that may be brought or made by any person having contractual or business relations with Assignor; and
(vi) all claims, actions or proceedings, or threatened claims, actions or proceedings, relating to or arising from Assignee not properly acquiring ownership of any of the Acquired Assets.
Neither Assignor no any Major Stockholder shall be responsible for any Damages to the extent that such Damages are due to the gross negligence or willful misconduct of Assignee. Notwithstanding anything herein to the contrary, the liability of each Major Stockholder shall not exceed in the aggregate the sum of (i) the Purchase Price proceeds paid or payable to such Major Stockholder under this Agreement plus (ii) the consideration paid to such Major Stockholder under his Non-Competition Agreement with the Company. The Parties agree that the Company may first foreclose upon any Shares held by the Company in escrow pursuant to the Escrow Agreement to satisfy any indemnification liabilities owing to Assignee under this Section 9.1 and such Shares shall be deemed to have a per share value equal to the weighted average of the closing sale prices for shares of Assignee Common Stock on the OTCQB Market of the OTC Markets Group (OTCQB: SCND) (or such other market or national quotation bureau on which Assignee's Common Stock is traded or quoted) for the last five trades effected prior to the final determination date of the relevant indemnifiable liability.
9.2. Indemnification Procedure.
(a) Claims Notice. Whenever any claim shall arise for indemnification under this Agreement (an "Indemnification Claim"), the person seeking indemnification (the "Indemnified Party") shall promptly notify the Party from whom indemnification is sought (the "Indemnifying Party") in writing of the Indemnification Claim ("Claim Notice"), which Claim Notice shall set forth such Indemnification Claim in reasonable detail. In the event of any such Indemnification Claim resulting from or in connection with any claim, demand or legal proceedings by a third party (a "Third-Party Claim"), the Claim Notice to the Indemnifying Party shall specify, if known, the amount or an estimate of the amount of the Damages arising therefrom. The failure of the Indemnified Party to give the Indemnifying Party prompt notice as provided herein shall not relieve the Indemnifying Party of any of its obligations under this Section 9, except to the extent that the Indemnifying Party is materially prejudiced by such failure.
(b) Conflicts Between the Parties. If the Claim Notice does not involve a Third-Party Claim, and if the Indemnifying Party objects in writing within ten (10) business days of its receipt of the Claim Notice to any indemnity in respect of any such Claim Notice, then the Indemnifying Party and the Indemnified Party sending such Claim Notice shall attempt in good faith to agree upon the rights of the respective parties with respect to the Indemnification Claim to which the Claim Notice relates. If the Indemnifying Party and the Indemnified Party so agree, the Indemnifying Party shall promptly make the agreed-upon payment.
(c) Third-Party Claims. The Indemnifying Party shall have thirty (30) days after receipt of the Claim Notice with respect to a Third-Party Claim to assume the conduct and control of the settlement or defense of such the Third-Party Claim, through counsel of its own choosing (but reasonably satisfactory to the Indemnified Party) and at the Indemnifying Party?s own expense, and the Indemnified Party shall cooperate with it in connection therewith; provided, that the Indemnified Party may participate in such settlement or defense through counsel chosen by such Indemnified Party and the fees and expenses of such counsel shall be borne by such Indemnified Party with no right to indemnification therefor unless (i) the employment thereof has been specifically authorized by the Indemnifying Party in writing, (ii) the Indemnified Party reasonably concludes (based on the advice of counsel) that there exists a conflict of interest between the interests of the Indemnified Party and the Indemnifying Party, or (iii) the Indemnifying Party has after a reasonable time failed to employ counsel to assume or to continue to maintain such defense, in each of which events the Indemnified Party may retain counsel which shall be reasonably satisfactory to the Indemnifying Party, and the Indemnifying Party shall pay the reasonable fees and expenses of such counsel for the Indemnified Party (but in no event shall the Indemnifying Party be obligated to pay fees and expenses of more than one firm for all Indemnified Parties). Except as otherwise provided in this Section 9.2(c), so long as the Indemnifying Party is reasonably contesting any such Third-Party Claim in good faith, the Indemnifying Party shall have the exclusive right to conduct and control the defense of the Third-Party Claim and the Indemnified Party shall not pay or settle any such Third-Party Claim without the consent of the Indemnifying Party. If the Indemnifying Party does not notify the Indemnified Party within thirty (30) days after the receipt of the Indemnified Party's Claim Notice with respect to a Third-Party Claim that it elects to undertake the defense thereof (or does not fulfill its commitment to undertake such defense), the Indemnified Party shall have the right to contest, settle or compromise the Third-Party Claim but shall not thereby waive any right to indemnity therefor pursuant to this Agreement. The Indemnifying Party shall not, except with the written consent of the Indemnified Party, consent to the entry of any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by the person asserting such Third-Party Claim of an unconditional release from all liability with respect to such Third-Party Claim to all Indemnified Parties (i.e., Assignor Indemnified Parties or Assignee Indemnified Parties, as the case may be).
(d) Third Party Beneficiaries. The Assignee
Indemnified Parties and Assignor Indemnified Parties are intended
to be third party beneficiaries of the rights granted under this
Section 9.2 and to have the right to enforce such rights directly
against the applicable Indemnifying Party.
9.3. Survival of Representation and Warranties. Notwithstanding any investigation conducted before or after the Closing, and notwithstanding any knowledge or notice of any fact or circumstance that either Assignor or Assignee may have as the result of such investigation or otherwise, the representations and warranties shall survive the Closing for a period of 6 years; provided, however, the representations and warranties contained in Sections 4.1, 4.2, 4.6, 4.11, 4.14 and 4.15 shall survive ndefinitely.
10. Miscellaneous.
10.1. Waivers and Amendments.
(a) This Agreement may be amended, modified
or supplemented only by a written instrument executed by the
Parties hereto.
(b) No waiver of any provision of this Agreement, or consent to any departure from the terms of this Agreement, shall be effective unless the same shall be in writing and signed by the Party waiving or consenting thereto. No failure on the part of any Party to exercise, and no delay in exercising, any right or remedy under this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or remedy by such Party preclude any other or further exercise thereof or the exercise of any other right or remedy. The waiver by any Party hereto of a breach of any provision of this Agreement shall not operate as a waiver of any subsequent breach. Except as otherwise specifically provided herein, all rights and remedies under this Agreement are cumulative and are in addition to and not exclusive of any other rights and remedies provided by Law.
10.2. Performance. Assignor and each Major Stockholder acknowledges that money damages alone will not adequately compensate Assignee for Assignor's or Assignor's Affiliates' breach of Section 7.6 or of Section 8, and, therefore, agrees that in the event of such breach or threatened breach, in addition to all other remedies available to Assignee, at law, in equity or otherwise, Assignee shall be entitled, if warranted, to an injunction restraining any such breach or threatened breach, or a decree of specific performance, without posting any bond or security. The remedy in this Section 10.2 is in addition to, and not in lieu of, any other rights or remedies Assignee may have.
10.3. Notices. Any notice required or permitted by this Agreement shall be in writing and shall be (a) delivered personally, effective on the date of delivery, (b) sent via an internationally recognized express international courier service, such as Federal Express or DHL, to be effective three (3) business days following deposit, or (c) sent by facsimile to be effective on the date of confirmed transmission, provided that a confirmation copy is sent no later than the next business day via an internationally recognized express international courier service, such as Federal Express or DHL. Notices shall be addressed to the Party concerned at the address indicated below or at such other address as such Party may subsequently designate by like notice from time-to-time:
(a) if to Assignor, to:
Fulcrum, Inc.
100 Delawanna Avenue, Suite 502
Clifton, New Jersey 07014
Attention: James Maloy, President
Telecopier No.: (973) 777-8302
with a required copy to:
Jeffrey Marks, Esq.
Law Office of Jeffrey D. Marks PC
415 Clifton Avenue.
Clifton, NJ 07011
Telecopier No.: (973) 253-8858
(b) if to a Major Stockholder, to:
James Maloy
Karl Nowosielski
c/o Fulcrum, Inc.
100 Delawanna Avenue
Clifton, NJ 07014
Telecopier No.: (973) 777-8302
(c) if to Assignee, to:
Scientific Industries, Inc.
70 Orville Drive
Bohemia, New York 11716
Attention: Helena R. Santos, President
Telecopier No.: (631) 567-5896
with a required copy to:
Reitler Kailas & Rosenblatt LLC.
885 Third Avenue, 20th floor
New York, New York 10022
Attention: John F. F. Watkins
Telecopier No.: (212) 371-5500
10.4. Expenses. Each Party hereto shall pay its own expenses in connection with the transactions contemplated by this Agreement, whether or not they are completed. In the event of any conflict between this provision and the indemnification or termination provisions of this Agreement, the indemnification or termination provisions, as the case may be, shall control.
10.5. Publicity. Except as required by applicable Law (but only if the Party affected by such Law shall have given the other Party or Parties advance written notice of the specific manner in which such requirements affect or modify the obligations that would otherwise apply to such Party under this Section 10.5), no Party shall use the name of the other Parties or any Affiliate of the other Parties in any publicity or advertising without the prior written approval of the other Parties. Except as may be required by applicable Law (and subject to the advance written notice described in the previous sentence), no Party shall disclose any terms or conditions of this Agreement without the prior written consent of the other Parties; provided, that Assignee may, without the prior consent of Assignor, make such public disclosure as may be required by Law or regulations of any stock exchange or other Governmental Authority.
10.6. Entire Agreement. This Agreement (including the Disclosure Schedule, the Appendices and the Exhibits) and the other Related Documents constitute the entire agreement between and among the Parties hereto with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, whether written or oral, between the Parties in connection with such subject matter.
10.7. Governing Law. This Agreement
shall be governed by, and construed and enforced in
accordance with, the substantive law of the State of New
York without giving effect to any conflict-of-law provision.
The Parties hereby irrevocably and unconditionally consent
to submit to the exclusive jurisdiction of the state and federal
courts located in New York for any actions, suits or proceedings
arising out of or relating to this Agreement (and each Party
agrees not to commence any action, suit or proceeding relating
thereto except in such courts), and further agree that service
of any process, summons, notice or document in accordance with
Section 10.3 hereof shall be effective service of process for
any action, suit or proceeding brought against the Parties in
any such court. The Parties hereby irrevocably and unconditionally
waive any objection to the laying of venue of any action, suit or
proceeding arising out of this Agreement in the state and federal
courts located in New York, and hereby further irrevocably and
unconditionally waive and agree not to plead or claim in any such
court that any such action, suit or proceeding brought in any such
court has been brought in an inconvenient forum.
10.8. Interpretation. When reference is made in this Agreement to a Section, such reference shall be to a Section of this Agreement, unless otherwise indicated. References to Sections include subsections, which are part of the related Section. The recitals hereto constitute an integral part of this Agreement. The table of contents and headings contained in this
Agreement are for convenience of reference only and shall not affect in any way the meaning or interpretation of this Agreement. The language used in this Agreement shall be deemed to be the language chosen by the Parties hereto to express their mutual intent, and no rule of strict construction shall be applied against any Party. Whenever the context may require, any pronouns used in this Agreement shall include the corresponding masculine, feminine or neuter forms, and the singular form of nouns and pronouns shall include the plural, and vice versa. Any reference to Law shall be deemed to refer to such Law as such Law may be in effect from time to time, unless the context requires otherwise. Whenever the words "include," "includes" or "including" are used in this Agreement, they shall be deemed to be followed by the words "without limitation." The term "or" shall have the inclusive meaning frequently identified with the phrase "and/or." No summary of this Agreement prepared by any Party shall affect the meaning or interpretation of this Agreement.
10.9. Modification. It is the intention of the Parties that this Agreement be enforced in accordance with its specific terms. However, if it should for some reason be contrary to public policy to effectuate the intentions of the Parties in interpreting this Agreement, the Parties have agreed as follows:
(a) In the event that any court to which a dispute is submitted determines that any provision of this Agreement is invalid or unenforceable by reason of its extending for too great a period of time or over too large a geographic area or over too great a range of activities, the Parties agree that the court shall have the power to reduce the scope, duration, or geographic area of the term or provision, to delete specific words or phrases, or to replace any invalid or unenforceable term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be enforceable as so modified after the expiration of the time within which the decision may be appealed.
(b) If the court shall determine that any provision of this Agreement is invalid, illegal or otherwise unenforceable, the validity, legality and enforceability of the other provisions of this Agreement shall not be affected thereby. Any invalid, illegal or unenforceable provision of this Agreement shall be severable, and after any such severance, all other provisions of this Agreement shall remain in full force and effect. In all such cases, the Parties shall use their reasonable best efforts to substitute a valid, legal and enforceable provision which, insofar as practicable, implements the original purposes and intents of this Agreement.
10.10. Severability. Any provision of this Agreement which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction.
10.11. Disclosure Schedule and Exhibits. The Disclosure Schedule and Exhibits mentioned in this Agreement shall be attached to this Agreement and shall form an integral part of this Agreement. All capitalized terms defined in this Agreement which are used in the Disclosure Schedule or any Exhibit shall, unless the context otherwise requires, have the same meaning therein as given herein.
10.12. Counterparts and Facsimile Signatures. This Agreement, the Disclosure Schedule and all Exhibits hereto may be executed in one or more counterparts, all of which shall be considered one and the same agreement and shall become effective when one or more counterparts have been signed by each Party and delivered to the other Party, it being understood that all Parties need not sign the same counterpart. Facsimile execution and delivery of this Agreement, the Disclosure Schedule and any Exhibits by any of the Parties shall be legal, valid and binding execution and delivery of such document for all purposes.
10.13. No Assignment by Assignor. This Agreement is personal to Assignee, and Assignor and the Major Stockholders shall not assign any of its rights or delegate any of its obligations under this Agreement without the prior written consent of Assignee, which consent may be withheld for any reason. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the Parties and their respective successors and permitted assigns. In addition, the rights to indemnification set forth in Section 9 shall inure to the benefit of and be enforceable by each of the indemnitees described therein. All assignees of this Agreement shall assume Assignor's obligations under this Agreement in writing. Without the consent of Assignor, Assignee may assign its rights under this Agreement and delegate its obligations under this Agreement, in whole or in part, to any person that shall acquire the Acquired Assets if such person shall assume their obligations under this Agreement in writing, or the merger or consolidation of Assignee with or into, any other person. Any attempt to assign or transfer this Agreement or any portion thereof in violation of this Section 10.13 shall be void.
10.14. Bulk Sales Laws. Assignee and Assignor each waives compliance by with the provisions of any applicable bulk sales law or other law for the protection of creditors or similar laws with respect to the sale of the Acquired Assets or the transactions contemplated by this Agreement. Assignor and each of the Major Stockholders agree to indemnify and hold Assignee harmless from, and to reimburse Assignor for, any and all liabilities which may be asserted by third parties against Assignee as a result of Assignor's or Assignee's noncompliance with such law; provided, however, such indemnity shall not apply to any penalty or fee (as distinct from an Assignor liability) that might be assessed against Assignee solely as a result of any failure to make any required filing under applicable bulk sales law.
10.15. Waiver of Jury Trial. EACH OF ASSIGNOR, ASSIGNEE AND EACH MAJOR STOCKHOLDER BY THIS AGREEMENT IRREVOCABLY AND UNCONDITIONALLY WAIVES ALL RIGHTS TO TRIAL BY JURY IN ANY LEGAL ACTION, PROCEEDING OR COUNTERCLAIM WITH RESPECT TO ANY MATTER WHATSOEVER ARISING OUT OF OR IN CONNECTION WITH OR RELATED TO THIS AGREEMENT OR THE OTHER RELATED DOCUMENTS OR THE ENFORCEMENT OF THIS AGREEMENT OR THEREOF.* * * * *
The remainder of this page has been intentionally left blank.
IN WITNESS WHEREOF, the undersigned have duly executed and
delivered this Agreement as of the date first above written.
FULCRUM, INC.
By: /s/ James Maloy ______________________ Name: James Maloy Title: President /s/ James Maloy ______________________ James Maloy /s/ Karl Nowosielski ______________________ Karl Nowosielski |
SCIENTIFIC INDUSTRIES, INC.
By: /s/ Helena Santos ___________________________ Name: Helena R. Santos Title: President |
Exhibit A
Form of Supply and Distribution Agreement
(See Tab 6)
Exhibit B
Form of Employment Agreement
Exhibit C
Form of Non-Competition Agreement
Exhibit D
Form of Legal Opinion
Exhibit E
Form of Registration Agreement
NON-COMPETITION AGREEMENT
THIS AGREEMENT dated as of February 26, 2014 (the "Agreement") by and between SCIENTIFIC INDUSTRIES, INC., (the "Company"), with the principal office of both at 70 Orville Drive, Bohemia, NY 11716 and James Maloy who resides at 252 Roseland Avenue, Essex Fells, NJ 07021 ("JM").
WHEREAS, the Company is acquiring on this date by assignment and sale from Fulcrum, Inc., a New Jersey corporation ("Assignor") in accordance with the Asset Purchase Agreement dated as of February 26, 2014 by and among the Company, Assignor, JM and Karl Nowosielski (the "Purchase Agreement"), substantially all of the assets of Assignor including, without limitation, the rights to Assignor's Balance and Scale Business (as defined in the Purchase Agreement);
WHEREAS, it is a condition to the Company's execution and delivery of the Purchase Agreement and performance of its obligations thereunder that JM enter into this Non-Competition Agreement with the Company.
NOW, THEREFORE, it is hereby agreed as follows:
1. Non-Competition; Non-Solicitation.
(a) In order to induce the Company to execute and deliver the Purchase Agreement and in consideration for the payment to JM of $135,000 ("Cash Consideration"), JM hereby agrees that during the Non-Competition Period, JM shall not, within the Non-Competition Area (as defined in Section 2 below), except as may be otherwise agreed by the Company in writing (i) perform services or otherwise act in any capacity (including without limitation as an employee, independent contractor, officer, director or consultant) for, or otherwise be engaged by or have any financial interest in or affiliation with, any individual corporation, partnership or any other entity involved in or which involves or relates to one or more of the Competitive Activities (as defined in Section 2 below); (ii) perform services (including without limitation as an employee, independent contractor, officer, director or consultant) for, or otherwise be engaged by or have any financial interest in or affiliation with any individual corporation, partnership or any other Competitor Entity (as defined in Section 2 below); or (ii) own 5% or more in the aggregate of the outstanding equity interests of any Competitor Entity. Notwithstanding the foregoing, nothing contained in this Paragraph 1 shall prevent JM from being an officer, director, employee or partner or owning an equity interest in a lessor or sublessor of a facility of which the Company is the lessee or sublessee at the time of the purchase.
(b) During the Non-Competition Period neither JM nor any of his affiliates will, directly or indirectly: (i) recruit, solicit or otherwise induce or influence any employee of the Company, or a direct or indirect subsidiary of the Company (the "SI Group") or a sales agent, joint venturer, lessor, supplier, agent, buyer or any other person who or which was an employee of or engaged by an SI Group member or has or had during the Non-Competition Period or during the one year period initially preceding the commencement of the Non-Competition Period a business relationship with a member of the SI Group, to discontinue, reduce or adversely modify such employment, agency or business relationship with a SI Group member or (ii) employ or seek to employ or cause any person to employ or seek to employ any person or agent who is employed or retained by a member of SI Group.
(c) Definitions. For purposes of this Agreement, the defined terms set forth below shall have the following meanings:
(i) "Competitive Activities" shall mean (i) developing or providing products or services which compete with the Balance and Scale Business of the Company; (ii) soliciting or endeavoring to entice away any person or entity who is or was a customer of the Company or any of is subsidiaries (collectively, a "Protected Entity") or encouraging any such person or entity to use any products or services which compete with the Balance and Scale Business of the Company; (iii) assisting any person or entity in any way to do, or attempt to do, anything prohibited by clauses (i) or (ii) above and (iv) directly or indirectly soliciting, recruiting or hiring any person employed by a Protected Entity; provided however this covenant shall not be deemed breached as a result of the ownership by Assignor or any Major Stockholder and their respective Affiliates of less than an aggregate of five (5%) percent of any class of stock of any publicly-traded entity engaged in Competitive Activities;
(ii) "Competitor Entity" shall mean any entity engaged in Competitive Activities.
(iii) "Non-Competition Period" shall mean the period commencing on the Closing Date as defined in the Purchase Agreement and ending on the fifth anniversary thereof.
(iv) "Restricted Area" shall mean the United States, Canada, Central America and South America.
2. JM acknowledges and agrees that the Company or its affiliates may be damaged irreparably in the event any of the provisions of this Agreement are breached. Accordingly, JM agrees that the Company or SI shall be entitled to an injunction or injunctions to prevent breaches of the provisions of this Agreement and to enforce specifically this Agreement and the terms and provisions hereof in any action instituted in any court of the United States or any state thereof having jurisdiction over the matter, without being required to secure a bond, in addition to any other remedy to which it may be entitled, at law or in equity. Without limiting the foregoing, JM shall be obligated to repay to the Company the Cash Consideration upon a material breach of his obligations under this Agreement.
3. If the final judgment of a court of competent jurisdiction declares that any term or provision of Section 1 above, is invalid or unenforceable, the parties to this Agreement agree that
the court making the determination of invalidity or unenforceability shall have the power to reduce the scope, duration or area of the term or provision, to delete specific words or phrases, or to replace any invalid or unenforceable term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be enforceable as so modified.
4. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE DOMESTIC LAWS OF THE STATE OF NEW YORK WITHOUT GIVING EFFECT TO ANY CHOICE OR CONFLICT OF LAW PROVISION OR RULE (WHETHER OF THE STATE OF NEW YORK OR ANY OTHER JURISDICTION) THAT WOULD CAUSE THE APPLICATION OF THE LAWS OF ANY JURISDICTION OTHER THAN THE STATE OF NEW YORK.
5. Each party submits exclusively to the jurisdiction of any state or federal court sitting in the Borough of Manhattan, New York in any action or proceeding arising out of or relating to this Agreement and agrees that all claims in respect of the action or proceeding may be heard and determined in any such court. Each party waives any defense of inconvenient forum to the maintenance of any action or proceeding so brought and waives any bond, surety, or other security that might be required of the other party with respect thereto. A party may make service on the other party by sending or delivering a copy of the process to the party to be served at the address set forth in the first paragraph of this Agreement, unless notified of a different address in writing by the party to be served.
SCIENTIFIC INDUSTRIES, INC. JAMES MALOY
/s/ Helena R. Santos /s/ James Maloy By: ____________________________ _______________________ Helena R. Santos, President |
NON-COMPETITION AGREEMENT
THIS AGREEMENT dated as of February 26, 2014 (the "Agreement") by and between SCIENTIFIC INDUSTRIES, INC., (the "Company"), with the principal office of both at 70 Orville Drive, Bohemia, NY 11716 and Karl Nowosielski who resides at 139 Pascack Rd. Pearl River NY 10965 (?KN?).
WHEREAS, the Company is acquiring on this date by assignment and sale from Fulcrum, Inc., a New Jersey corporation ("Assignor") in accordance with the Asset Purchase Agreement dated as of February 26, 2014 by and among the Company, Assignor, KN and James Maloy (the "Purchase Agreement"), substantially all of the assets of Assignor including, without limitation, the rights to Assignor's Balance and Scale Business (as defined in the Purchase Agreement);
WHEREAS, it is a condition to the Company's execution and delivery of the Purchase Agreement and performance of its obligations thereunder that KN enter into this Non-Competition Agreement with the Company.
NOW, THEREFORE, it is hereby agreed as follows:
1. Non-Competition; Non-Solicitation.
(a) In order to induce the Company to execute
and deliver the Purchase Agreement and in consideration for
the payment to KN of $135,000 ("Cash Consideration"), KN
hereby agrees that during the Non-Competition Period, KN shall
not, within the Non-Competition Area (as defined in Section 2
below), except as may be otherwise agreed by the Company in
writing (i) perform services or otherwise act in any capacity
(including without limitation as an employee, independent
contractor, officer, director or consultant) for, or otherwise
be engaged by or have any financial interest in or affiliation
with, any individual corporation, partnership or any other
entity involved in or which involves or relates to one or more
of the Competitive Activities (as defined in Section 2 below);
(ii) perform services (including without limitation as an employee,
independent contractor, officer, director or consultant) for, or
otherwise be engaged by or have any financial interest in or
affiliation with any individual corporation, partnership or
any other Competitor Entity (as defined in Section 2 below); or
(ii) own 5% or more in the aggregate of the outstanding equity
interests of any Competitor Entity. Notwithstanding the
foregoing, nothing contained in this Paragraph 1 shall prevent KN
from being an officer, director, employee or partner or owning
an equity interest in a lessor or sublessor of a facility of
which the Company is the lessee or sublessee at the time of
the purchase.
(b) During the Non-Competition Period neither KN nor any of his affiliates will, directly or indirectly: (i) recruit, solicit or otherwise induce or influence any employee of the Company, or a direct or indirect subsidiary of the Company (the ?SI Group?) or a sales agent, joint venturer, lessor, supplier, agent, buyer or any other person
who or which was an employee of or engaged by an SI Group member or has or had during the Non-Competition Period or during the one year period initially preceding the commencement of the Non-Competition Period a business relationship with a member of the SI Group, to discontinue, reduce or adversely modify such employment, agency or business relationship with a SI Group member or (ii) employ or seek to employ or cause any person to employ or seek to employ any person or agent who is employed or retained by a member of SI Group.
(c) Definitions. For purposes of this Agreement, the defined terms set forth below shall have the following meanings:
(i) "Competitive Activities" shall mean (i) developing or
providing products or services which compete with the Balance
and Scale Business of the Company; (ii) soliciting or
endeavoring to entice away any person or entity who is or was
a customer of the Company or any of is subsidiaries
(collectively, a ?Protected Entity?) or encouraging any such
person or entity to use any products or services which compete
with the Balance and Scale Business of the Company; (iii)
assisting any person or entity in any way to do, or attempt
to do, anything prohibited by clauses (i) or (ii) above and
(iv) directly or indirectly soliciting, recruiting or hiring
any person employed by a Protected Entity; provided however
this covenant shall not be deemed breached as a result of the
ownership by Assignor or any Major Stockholder and their
respective Affiliates of less than an aggregate of five (5%)
percent of any class of stock of any publicly-traded entity
engaged in Competitive Activities;
(ii) "Competitor Entity" shall mean any entity engaged in Competitive Activities.
(iii) "Non-Competition Period" shall mean the period commencing on the Closing Date as defined in the Purchase Agreement and ending on the fourth anniversary thereof.
(iv) "Restricted Area" shall mean the United States, Canada, Central America and South America.
2. KN acknowledges and agrees that the Company or its affiliates may be damaged irreparably in the event any of the provisions of this Agreement are breached. Accordingly, KN agrees that the Company or SI shall be entitled to an injunction or injunctions to prevent breaches of the provisions of this Agreement and to enforce specifically this Agreement and the terms and provisions hereof in any action instituted in any court of the United States or any state thereof having jurisdiction over the matter, without being required to secure a bond, in addition to any other remedy to which it may be entitled, at law or in equity. Without limiting the foregoing, KN shall be obligated to repay to the Company the Cash Consideration upon a material breach of his obligations under this Agreement.
3. If the final judgment of a court of competent jurisdiction declares that any term or provision of Section 1 above, is invalid or unenforceable, the parties to this Agreement agree that
the court making the determination of invalidity or unenforceability shall have the power to reduce the scope, duration or area of the term or provision, to delete specific words or phrases, or to replace any invalid or unenforceable term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be enforceable as so modified.
4. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE DOMESTIC LAWS OF THE STATE OF NEW YORK WITHOUT GIVING EFFECT TO ANY CHOICE OR CONFLICT OF LAW PROVISION OR RULE (WHETHER OF THE STATE OF NEW YORK OR ANY OTHER JURISDICTION) THAT WOULD CAUSE THE APPLICATION OF THE LAWS OF ANY JURISDICTION OTHER THAN THE STATE OF NEW YORK.
5. Each party submits exclusively to the jurisdiction of any state or federal court sitting in the Borough of Manhattan, New York in any action or proceeding arising out of or relating to this Agreement and agrees that all claims in respect of the action or proceeding may be heard and determined in any such court. Each party waives any defense of inconvenient forum to the maintenance of any action or proceeding so brought and waives any bond, surety, or other security that might be required of the other party with respect thereto. A party may make service on the other party by sending or delivering a copy of the process to the party to be served at the address set forth in the first paragraph of this Agreement, unless notified of a different address in writing by the party to be served.
SCIENTIFIC INDUSTRIES, INC. KARL NOWOSIELSKI /s/ Helena R. Santos /s/ Karl Nowosielski By:____________________________ ____________________ Helena R. Santos, President |
REGISTRATION RIGHTS AGREEMENT
THIS REGISTRATION RIGHTS AGREEMENT is entered into as of February 26, 2014, by and between Scientific Industries, Inc., a Delaware corporation (the "Company"), and Fulcrum, Inc., a New Jersey corporation (the "Stockholder").
WHEREAS, a condition to the sale by the Stockholder to the Company of certain of the Stockholder?s assets pursuant to the Agreement is that the Company provide certain rights to register under the Securities Act, under certain conditions, the Common Shares received by the Stockholder as part of the sale consideration,
NOW THEREFORE, IT IS HEREBY AGREED that:
1. Definitions. As used herein, the following terms shall have the following meanings ascribed to them below:
"Affiliate" means any Person that has a relationship with a designated Person whereby either of such Persons directly or indirectly controls or is controlled by or is under common control with the other. For this purpose "control" means the power, direct or indirect, of one Person to direct or cause direction of the management and policies of another, or any act with respect to the securities of the Company, whether by contract, through voting securities or otherwise.
"Agreement" means the Asset Purchase Agreement between the Company, the Stockholder, James Maloy, and Karl Nowosielski, dated as of the date hereof.
"Common Shares" shall mean the shares of Common Stock issued to the Stockholder pursuant to the Agreement.
"Common Stock" shall be the Company's authorized common stock, as constituted on the date of the Agreement, any stock into which such common stock may thereafter be changed and any stock of the Company of any other class, which is not preferred as to dividends or assets over any other class of stock of the Company issued to the Stockholders of shares of such common stock upon any re-classification thereof.
"Company Registration Expenses" shall mean bills or invoices (other than Selling Expenses) incident to the Company?s performance of or compliance with the Agreement including, without limitation, all registration, filing fees, fees and expenses of compliance with securities or blue sky laws, word processing, duplicating and printing expenses, messenger and delivery expenses, fees and disbursements of counsel for the Company and all independent public accountants including the expenses of any audit and/or "cold comfort" letter, if applicable, and other Persons retained by the Company.
"Controlling Person" shall have the meaning set forth under Section 15 of the Securities Act.
"Exchange Act" means the Securities Exchange Act of 1934, as amended.
"Excluded Form" means a Form S-4 or Form S-8, pursuant to the Securities Act or any similar or successor form then in effect.
"Indemnified Party" shall mean a party who is entitled to indemnification under Section 8 of the Agreement and shall refer either to (a) the Company, and (b) its directors, officers, agents, counsel, advisors and Controlling Persons, if any.
"Person" means a corporation, an association, a
partnership, a limited liability company, a joint venture, a
trust, an organization, a business, an entity, an individual,
a government or political subdivision thereof or a governmental
body.
"Register, registered and registration" means a
registration effected by preparing and filing a Registration
Statement on a form approved by the SEC other than an Excluded
Form in compliance with the Securities Act and the declaration
of effectiveness ordering the effectiveness of such Registration
Statement.
"Registrable Securities" means the Common Shares and such additional shares of Common Stock by way of stock dividend or stock split, or in connection with a combination, recapitalization, share exchange, consolidation or other reorganization of the Company. As to any Registrable Securities, once issued, such securities shall cease to be Registrable Securities when (i) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been disposed of in accordance with such Registration Statement, (ii) they shall have been sold to the public pursuant to Rule 144 (or any successor provision) under the Securities Act, (iii) they shall have been otherwise transferred but new certificates for them not bearing a legend restricting further transfer shall have been delivered by the Company and subsequent disposition of them shall not require registration or qualification of them under the Securities Act or any similar state law then in force, or (iv) they shall have ceased to be outstanding.
"Registration Statement" means one or more registration statements of the Company on any form other than an Excluded Form under the Securities Act registering all of the Registrable Securities, including any amendments or supplements thereto.
"SEC" means the Securities and Exchange Commission or any other governmental body at the time administering the Securities Act.
"Securities Act" means the Securities Act of 1933, as amended.
"Selling Expenses" shall mean all underwriting discounts and selling commissions applicable to the Registrable Securities registered, all fees and disbursements of counsel for the Stockholder and the expense allowance payable or which is to be paid to any placement agent or
any of their respective Affiliates or associates pursuant to the placement agent agreement or to any underwriter of the Registrable Securities.
"Stockholder" or "Stockholders" shall also include those persons who agree to become bound by the provisions of the Agreement in accordance with Section 5 hereof.
2. Registration.
2.1. If the Company shall determine to prepare and file with the SEC a registration statement relating to an offering to commence no earlier than a date one year from the date hereof for its own account or the account of others under the Securities Act of any of its equity securities (other than a Registration Statement on an Excluded Form), then the Company shall send to each Stockholder holding Registrable Securities that have not been covered by a registration statement that has been declared or ordered effective (each, an ?Eligible Stockholder?), written notice of such determination and if, within 15 business days after receipt of such notice any such Eligible Stockholder shall so request in writing, the Company shall include in such registration statement the Registrable Securities requested by the Eligible Stockholders to be so included. Such written notice shall state the intended method of disposition of the Registrable Securities by such Eligible Stockholder. If an Eligible Stockholder decides not to include all of its Registrable Securities in any registration statement thereafter filed by the Company, such Eligible Stockholder shall nevertheless continue to have the right to include any Registrable Securities in any subsequent registration statement or registration statements as may be filed by the Company with respect to offerings of its securities, all upon the terms and conditions set forth herein, to the extent all Registrable Securities held by such Stockholder have not been covered by a registration statement that has been declared or ordered effective by the time of such subsequent registration.
2.2 If the registration statement under which the Company gives notice under this Section 2 is for an underwritten offering, the Company shall so advise the Eligible Stockholders of Registrable Securities. In such event, the right of any such Eligible Stockholder to be included in a registration pursuant to this Section 2 shall be conditioned upon such Eligible Stockholder?s participation in such underwriting and the inclusion of such Eligible Stockholder?s Registrable Securities in the underwriting to the extent provided herein. All Eligible Stockholders proposing to distribute their Registrable Securities through such underwriting shall enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such underwriting by the Company. Notwithstanding any other provision of the Agreement, if the underwriter determines in good faith that marketing factors require a limitation of the number of shares to be underwritten, the number of shares that may be included in the underwriting shall be allocated, first, to the Company; and second on a pro rata basis, to the Eligible Stockholders and any other shareholders of the Company exercising registration rights based on the total number of Registrable Securities sought to be registered in such registration by the Eligible Stockholders and such other shareholder of the Company.
2.3 If any Eligible Stockholder disapproves of the terms of any such underwriting, such Eligible Stockholder may elect to withdraw therefrom by written notice to the Company and the underwriter, delivered at least ten (10) business days prior to the effective date of the
registration statement. Any Registrable Securities excluded or withdrawn from such underwriting shall be excluded and withdrawn from the registration. The estate and family members of any Eligible Stockholder and any trusts for the benefit of any of the foregoing persons shall be deemed to be a single "Eligible Stockholder," and any pro rata reduction with respect to such "Eligible Stockholder" shall be based upon the aggregate amount of shares carrying registration rights owned by all individuals and trusts included in such ?Eligible Stockholder,? as defined in this sentence.
2.4 The Company shall have the right to terminate or withdraw any registration initiated by it under this Section 2 prior to the effectiveness of such registration whether or not any Eligible Stockholder has elected to include securities in such registration.
3. Registration Procedures.
3.1 If and whenever the Company is required by the provisions hereof to effect or cause the registration of any Registrable Securities under the Securities Act as provided herein, the Company shall, as expeditiously as possible:
3.1.1 before filing a Registration Statement or prospectus or any amendments or supplements thereto, the Company shall furnish to the Stockholders copies of all such documents proposed to be filed.
3.1.2 prepare and file with the SEC such amendments (including post-effective amendments) and supplements to such Registration Statement and the prospectus used in connection therewith as may be necessary to keep such Registration Statement effective, true and correct during the Registration Period meaning the period commencing with the effective date and ending on the earlier of (i) the sale of all Registrable Securities covered thereby, (ii) the date upon which the Stockholders may sell the Registrable Securities, without volume limitations, pursuant to Rule 144, or (iii) the expiration of 18 months after the effective date of the Registration Statement or such shorter period as shall be necessary to complete the distribution of the securities covered thereby, and to comply with the provisions of the Securities Act with respect to the sale or other disposition of all Registrable Securities covered by such Registration Statement during such period in accordance with the intended methods of disposition by the Stockholders in such Registration Statement.
3.1.3 furnish to each Stockholder whose Registrable Securities are included in the Registration Statement and each underwriter of the securities being sold by the Stockholders such number of copies of such Registration Statement and of each such amendment and supplement thereto (in each case including all exhibits), such number of copies of the prospectus included in such Registration Statement (including each preliminary prospectus), in conformity with the requirements of the Securities Act, and such other documents, as such counsel and underwriter may reasonably request, in substantially the form in which they are proposed to be filed with the SEC, in order to facilitate the public sale or other disposition of the Registrable Securities owned by the participating Stockholders. The Company shall furnish to each Stockholder which requests (i) a copy of any request to accelerate the effectiveness of any Registration Statement or amendment thereto, (ii) on the date of effectiveness of the Registration
Statement or any amendment thereto, a notice stating that the Registration Statement or amendment has been declared effective, and (iii) such number of copies of a prospectus, including a preliminary prospectus, and all amendments and supplements thereto and such other documents as such Stockholder may reasonably request in order to facilitate the disposition of the Registrable Securities owned by such Stockholder.
3.1.4 use reasonable commercial efforts to (i) register
and qualify the Registrable Securities covered by the Registration
Statement under such other securities or ?blue sky? laws of such
jurisdictions in the United States as each Stockholder who holds
Registrable Securities being offered reasonably requests,
(ii) prepare and file in those jurisdictions such amendments
(including post-effective amendments) and supplements to such
registrations and qualifications as may be necessary to maintain
the effectiveness thereof during the Registration Period,
(iii) take such other actions as may be reasonably necessary
to maintain such registrations and qualifications in effect at
all times during the Registration Period, and (iv) take all
other actions reasonably necessary or advisable to qualify the
Registrable Securities for sale in such jurisdictions; provided,
however, that the Company shall not be required in connection
therewith or as a condition thereto to qualify to do business
in any jurisdiction where it would not otherwise be required
to qualify but for this Section 3.1.4;
3.1.5 subject to Section 3.1.4, use its reasonable commercial efforts to cause such Registrable Securities covered by such Registration Statement to be registered with or approved by such other governmental agencies or authorities as may be reasonably necessary to enable the participating Stockholders to consummate the disposition of its Registrable Securities;
3.1.6 notify the participating Stockholders at any time when a prospectus relating to its Registrable Securities is required to be delivered under the Securities Act, of the Company?s becoming aware that the prospectus included in the related Registration Statement, as then in effect, includes an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing, and promptly prepare and furnish to the participating Stockholders and each underwriter a reasonable number of copies of a prospectus supplemented or amended so that, as thereafter delivered to the purchasers of such Registrable Securities, such prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing;
3.1.7 otherwise use its reasonable commercial efforts to comply with all applicable rules and regulations of the SEC;
3.1.8 if the Common Stock is listed on the American Stock Exchange, another national securities exchange, the Nasdaq Stock Market, or on the NASD Over-the-Counter Bulletin Board, as the case may be, the Company shall use its reasonable commercial efforts to cause all such Registrable Securities covered by such Registration Statement to be listed on the American Stock Exchange, other national securities exchange, on the Nasdaq Stock Market, or on the NASD Over-the-Counter Bulletin Board, as the case may be (if such Registrable Securities are not already so listed), if the listing of such Registrable Securities is then permitted under the rules of such exchange or market;
3.1.9 in the case of an underwritten offering, enable the Registrable Securities to be in such denominations and registered in such names as the underwriters may request at least two business days prior to the sale of the Registrable Securities;
3.1.10 cooperate with the Stockholders who hold Registrable Securities being offered to facilitate the timely preparation and delivery of certificates (not bearing any restrictive legends) representing Registrable Securities to be offered pursuant to the Registration Statement and enable such certificates to be in such denominations or amounts, as the case may be, as the Stockholders may reasonably request and registered in such names as the Stockholders may request;
3.1.11 notify the Stockholders of any stop order threatened, to the knowledge of the Company, or issued by the SEC and take all actions reasonably necessary to prevent the entry of such stop order or to remove it if entered;
3.1.12 make available for inspection by one firm of attorneys and one firm of accountants or other agents retained by the holders of a majority of the Common Shares (collectively, the "Inspectors") based on the number of shares of Common Stock owned by the Stockholders, pertinent financial and other records, and pertinent corporate documents and properties of the Company, as shall be reasonably deemed necessary by each Inspector to enable each Inspector to exercise its due diligence responsibility, and cause the Company's officers, directors and employees to supply all information which any Inspector may reasonably request for purposes of such due diligence;
3.1.13 instruct the Company's transfer agent to remove the restrictive legend on the stock certificates after effectiveness of the applicable Registration Statement and provide with the cooperation of the Stockholders, any required legal opinions at the Company?s sole expense.
3.2 In connection with the registration of the Registrable Securities, each participating Stockholder shall furnish to the Company in writing such information and documents regarding it and the distribution of its securities as may reasonably be required to be disclosed in the Registration Statement in question by the rules and regulations under the Securities Act or under any other applicable securities or blue sky laws of the jurisdictions referred to in Section 3.1.4 above, or as may otherwise be reasonably requested.
4. Registration Expenses. In connection with any registration of Registrable Securities pursuant to Section 2, the Company shall, whether or not any such registration shall become effective, from time to time promptly pay all Company Registration Expenses. Such expenses shall not include any Selling Expenses other than reasonable fees and expenses of one counsel selected by holders of a majority of the Eligible Securities included in the Registration Statement.
5. Indemnification.
5.1 The Company shall, and hereby does, indemnify, to the extent permitted by law, each Stockholder from and against all losses, claims, damages, liabilities and expenses, joint or several, to which any such Indemnified Party may become subject under the Securities Act, the Exchange Act and all rules and regulations under each such Act, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon (i) any untrue statement or alleged untrue statement of a material fact contained in any Registration Statement as contemplated hereby or any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, (ii) any untrue statement or alleged untrue statement of a material fact contained in any preliminary, final or summary prospectus, together with the documents incorporated by reference therein (as amended or supplemented if the Company shall have filed with the SEC, any amendment thereof or supplement thereto), or any omission or alleged omission to state therein a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, or (iii) any violation by the Company of any federal, state or common law rule or regulation applicable to the Company and relating to action of or inaction by the Company in connection with any such registration including the failure to deliver any document required herein to be delivered, to a Stockholder; and in each such case, the Company shall reimburse each such Indemnified Party for any reasonable legal or other expenses incurred by any of them in connection with investigating or defending any such loss, claim, damage, liability, expense, action or proceeding; provided, however, that the Company shall not be liable to any such Indemnified Party insofar as such losses, claims, damages, liabilities, expenses, actions or proceedings are caused by any untrue statement or alleged untrue statement or material omission made in reliance on or in conformity with any information furnished under Section 5.2 to the Company by or on behalf of any Indemnified Party or as a result of the failure of the Indemnified Party to furnish a prospectus to a purchaser.
5.2 In connection with any Registration Statement in which any Stockholder is participating, such participating parties shall furnish to the Company in writing such information as shall be reasonably requested by the Company for use in any such Registration Statement or prospectus and shall indemnify, to the extent permitted by law, the Company, its officers and directors and each Person, if any, who controls the Company within the meaning of Section 15 of the Securities Act, against any losses, claims, damages, liabilities, expenses, actions or proceedings resulting from any untrue statement or alleged untrue statement of a material fact or any omission or alleged omission of a material fact with respect to information expressly requested by the Company and required to be stated in the Registration Statement or prospectus or preliminary prospectus or any amendment thereof or supplement thereto, or necessary to make the statements therein not misleading, but only to the extent that such untrue statement or omission with respect to information expressly requested by the Company is made in reliance on or in conformity with any information so furnished in writing or to be furnished under this Section 5.2 by such participating Stockholder expressly for use therein.
5.3 Any Person entitled to indemnification under the provisions of this Section 5 shall (i) give prompt notice to the Indemnifying Party of any claim with respect to which t seeks indemnification, and (ii) unless in the reasonable judgment of counsel for such Indemnified Party a conflict of interest between such indemnified and indemnifying parties may exist in respect of
such claim, permit such Indemnifying Party to assume the defense of such claim, with counsel reasonably satisfactory to the Indemnified Party; and if such defense is so assumed, such Indemnifying Party shall not enter into any settlement without the consent of the Indemnified Party if such settlement attributes liability to the Indemnified Party and such Indemnifying Party shall not be subject to any liability for any settlement made without its consent. In the event an Indemnifying Party shall not be entitled, or elects not, to assume the defense of a claim, such Indemnifying Party shall not be obligated to pay the fees and expenses of more than one law firm for all parties indemnified by such Indemnifying Party hereunder in respect of such claim, unless in the reasonable judgment of any such counsel a conflict of interest may exist between such Indemnified Party and any other of such Indemnified Parties in respect to such claim. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of any Indemnified Party and shall survive the transfer of such securities by such Indemnified Party.
5.4 If for any reason the foregoing indemnity
is unavailable, then the Indemnifying Party shall
contribute to the amount paid or payable by the Indemnified
Party as a result of such losses, claims, damages,
liabilities or expenses in such proportion as is appropriate
to reflect the relative fault of the Indemnifying Party and
the Indemnified Party as well as any other relevant equitable
considerations. Notwithstanding the foregoing, no Stockholder
shall be required to contribute any amount in excess of the
amount such Stockholder would have been required to pay to
an Indemnified Party if the indemnity under Section 5.2 was
available. No Person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act)
shall be entitled to contribution from any Person who was
not guilty of such fraudulent misrepresentation.
5.5 An Indemnifying Party shall make payments of all amounts required to be made pursuant to the foregoing provisions of this Section 5 to or for the account of the Indemnified Party from time to time promptly upon receipt of bills or invoices relating thereto or when otherwise due and payable.
6. Transfer of Registration Rights.
If and to the extent that any Stockholder sells or otherwise disposes of Registrable Securities in any transaction that does not require registration under the Securities Act (other than a transaction exempt under Rule 144), the rights of the Stockholder hereunder with respect to such Registrable Securities shall be assignable to any transferee of such Registrable Securities; provided, however, that such transferee agrees in writing to be bound by all the terms and conditions of the Agreement.
7. Miscellaneous.
7.1 The registration rights provided to the Stockholder of Registrable Securities hereunder shall terminate on the date there shall no longer be any outstanding Registrable Securities; provided, however that the provisions of Section 5 hereof shall survive any termination of the Agreement.
7.2 All notices, offers, acceptance and any other acts under the Agreement shall be in writing, and shall be sufficiently given if delivered to the addressees in person, by Federal Express or similar receipted overnight delivery, or by facsimile or e-mail delivery followed by a copy sent by Federal Express or similar receipted overnight delivery, as follows:
If to the Company:
Scientific Industries, Inc.
70 Orville Drive.
Bohemia, New York 11716
Facsimile No.: 631-567-5896
Attention: Ms. Helena R. Santos
Chief Executive Officer
With a copy to:
Reitler Kailas & Rosenblatt LLC
885 Third Avenue, 20th Floor
New York, NY 10022
Facsimile No.: (212) 371-5500
Attention: Leo Silverstein, Esq.
If to a Stockholder, at such address as such Stockholder shall have provided in writing to the Company or such other address as such Stockholder furnishes by notice given in accordance with this Section 7.2.
7.3 The rights and obligations herein shall inure to the benefit of and be binding upon the successors and assigns of each of the parties hereto.
7.4 This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument
[REMAINDER OF THE PAGE INTENTIONALLY LEFT BLANK.]
IN WITNESS WHEREOF, the parties hereto have executed this Registration Rights Agreement as of the date first set forth above.
COMPANY:
SCIENTIFIC INDUSTRIES, INC.
/s/ Helena R. Santos By: ________________________________ Name: Helena R. Santos Title: Chief Executive Officer |
STOCKHOLDER:
FULCRUM, INC.
/s/ James S. Maloy By: ________________________________ Name: James Maloy Title: President |
ESCROW AGREEMENT, dated as of February 26, 2014 (this "Agreement"), is made by and among SCIENTIFIC INDUSTRIES, INC., a Delaware corporation (the "Company"), FULCRUM, INC., a New Jersey corporation (?Fulcrum?), and REITLER KAILAS & ROSENBLATT LLC, as escrow agent (the "Escrow Agent").
RECITALS
The Company and Fulcrum are parties to that certain Asset Purchase Agreement, dated as of the date hereof (the "Purchase Agreement"), providing for the acquisition by the Company and sale by Fulcrum of the assets of Fulcrum described in the Purchase Agreement. The Purchase Agreement provides that 31,612 shares of the Company's Common Stock registered in the name of Fulcrum (the "Escrowed Shares") of the acquisition consideration is to be deposited with the Escrow Agent to be held and disbursed pursuant to the terms of the Purchase Agreement and this Agreement.
Capitalized terms not otherwise defined herein shall have the meanings set forth in the Purchase Agreement.
NOW THEREFORE, it is agreed as follows:
1. Appointment of Escrow Agent. The Company and Fulcrum hereby appoint the Escrow Agent, and the Escrow Agent hereby agrees to serve, as escrow agent in accordance with, and pursuant to, this Agreement.
2. Delivery of Escrowed Shares.
(a) As soon as practicable but no later than
three (3) business days following the Closing Date,
the Company, pursuant to the terms of the Purchase
Agreement, shall deliver to the Escrow Agent the
Escrowed Shares to be held pursuant to the terms of
this Agreement and the Purchase Agreement. Subject to
Section 2(b) of this Agreement, the Escrowed Shares shall
be delivered to Fulcrum on the first anniversary of the
Closing Date. During such escrow period, Fulcrum shall be
entitled to receive dividends paid by the Company with
respect to the Escrowed Shares. Fulcrum shall not assign
any of the Escrowed Shares or any interest thereon during
the period such Escrowed Shares are held. During such
period the stock certificates for the Escrowed Shares shall
bear in addition to the legend set forth in Section 4.17
of the Purchase Agreement, the following legend which shall
be deleted upon delivery of the Escrowed Shares pursuant
to this Agreement.
"THE SHARES EVIDENCED BY THIS CERTIFICATE
ARE SUBJECT TO THE TERMS OF AN ESCROW
AGREEMENT, DATED FEBRUARY 26, 2014, AND
SUCH SHARES OR ANY INTEREST THEREIN MAY NOT BE ASSIGNED DURING THE RELATED ESCROW PERIOD."
(b) The undersigned parties agree that the Company
may foreclose upon the Escrowed Shares in accordance with
Section 9.1 of the Purchase Agreement.
3. Voting of Escrowed Shares. During the escrow period, the Company agrees to provide to Fulcrum with respect to the Escrowed Shares copies of all materials provided to the stockholders of the Company with respect to the voting of such shares and copies of written communication delivered to stockholders pursuant to the Company's Certificate of Incorporation, By-Laws and the Rules and Regulations under the Securities Exchange Act of 1934, as amended.
4. Escrow Agent.
(a) The Escrow Agent shall receive no fee for its services hereunder. The Escrow Agent shall be entitled to reimbursement, within 15 days of presentation of appropriate documented invoices, from the Company, of the Escrow Agent's reasonable expenses incurred to third parties in the performance of its duties hereunder; provided, however, the Escrow Agent shall not be entitled to reimbursement for fees incurred in connection with the negotiation and preparation of this Agreement or in connection with acting as Escrow Agent.
(b) To induce the Escrow Agent to act hereunder, it is further agreed that:
(i) The Escrow Agent shall not be under any duty to give the Escrowed Shares held by it hereunder any greater degree of care than it gives its own similar property.
(ii) This Agreement expressly sets forth all the duties of the Escrow Agent with respect to any and all matters pertinent hereto. No implied duties or obligations shall be read into this Agreement against the Escrow Agent. The Escrow Agent shall not be bound by the provisions of any agreement among the other parties hereto (including the Purchase Agreement), except this Agreement.
(iii) The Escrow Agent shall not be liable, except for its own gross negligence or willful misconduct, and, except with respect to claims based upon such gross negligence or willful misconduct that are successfully asserted against the Escrow Agent, the other parties hereto shall jointly and severally indemnify and hold harmless the Escrow Agent (and any successor Escrow Agent) from and against any and all losses, liabilities, claims, actions, damages, and expenses, including reasonable attorneys' fees and disbursements, arising out of, and in connection with, this Agreement. In no event shall the Escrow Agent be liable for consequential, indirect or punitive damages. This paragraph shall survive termination of this Agreement.
(iv) The Escrow Agent shall be entitled to rely upon any order, judgment, certification, demand, notice, instrument, or other writing delivered to it hereunder without being required to determine the authenticity or the correctness of any fact stated therein or the propriety or validity of the service thereof. The Escrow Agent may act in reliance upon any instrument or signature believed by it in good faith to be genuine and may assume, if in good faith, that any person purporting to give notice or receipt or advice or make any statement or execute any document in connection with the provisions hereof has been duly authorized to do so. The Escrow
Agent shall not be liable for any action taken or omitted in good faith and in accordance with such advice.
(v) The Escrow Agent does not have any interest in
the Escrowed Shares deposited hereunder (except as provided in
Section 4(a)), but is serving as escrow holder only.
(vi) The Escrow Agent (and any successor escrow agent) at any time may be discharged from its duties and obligations hereunder by the delivery to it of notice of termination signed by the Company and Fulcrum or at any time may resign by giving written notice to such effect to the Company and Fulcrum. Upon any such termination or resignation, the Escrow Agent shall deliver the Escrowed Shares to any successor escrow agent jointly designated by the other parties hereto in writing, or to any court of competent jurisdiction if no such successor escrow agent is agreed upon, whereupon the Escrow Agent shall be discharged of and from any and all further obligations arising in connection with this Agreement. The termination or resignation of the Escrow Agent shall take effect on the earlier of (A) the appointment of a successor (including a court of competent jurisdiction) or (B) the twentieth day after the date of delivery: (1) to the Escrow Agent of the other parties? notice of termination or (2) to the other parties hereto of the Escrow Agent?s written notice of resignation. If at that time the Escrow Agent has not received a designation of a successor escrow agent, the Escrow Agent?s sole responsibility after that time shall be to keep the Escrowed Shares safe until receipt of a designation of successor escrow agent or a joint written disposition instruction by the other parties hereto or an enforceable order of a court of competent jurisdiction.
(vii) The Escrow Agent shall have no responsibility for the contents of any writing of any third party contemplated herein as a means to resolve disputes and may rely without any liability upon the contents thereof.
(viii) In the event of any dispute among or between the other parties hereto resulting in adverse claims or demands being made in connection with the Escrowed Shares or in the event that the Escrow Agent in good faith is in doubt as to what action it should take hereunder, the Escrow Agent shall retain the Escrowed Shares until the Escrow Agent shall have received (A) a final and non-appealable order of a court of competent jurisdiction directing delivery of the Escrowed Shares or (B) a written agreement executed by the other parties hereto directing delivery of the Escrowed Shares, in which event the Escrow Agent shall release and distribute the Escrowed Shares in accordance with such order or agreement. The Escrow Agent shall act on such court order without further question.
(ix) The parties hereto irrevocably (A) submit to the jurisdiction of any state or federal court sitting in New York County, New York in any action or proceeding arising out of, or relating to, this Agreement, (B) agree that all claims with respect to such action or proceeding shall be heard and determined in such state or federal court, and (C) waive, to the fullest extent possible, the defense of an inconvenient forum. The parties hereby consent to and grant any such court jurisdiction over the persons of such parties and over the subject matter of any such dispute and agree that delivery or mailing of process or other papers in connection with any such action or proceeding in the manner provided hereinabove, or in such other manner as may be permitted by law, shall be valid and sufficient service thereof.
(x) No publicly distributed material or other matter in any language which mentions the Escrow Agent's name or the rights, powers, or duties of the Escrow Agent shall be issued by the other parties hereto or on such parties' behalf unless the Escrow Agent shall first have given its specific written consent thereto.
(xi) Distribution of the Escrowed Shares pursuant to this Agreement by the Escrow Agent shall operate to divest all right, title, interest, claim and demand, either at law or in equity, of any party to this Agreement in and to the Escrowed Shares, and shall be a perpetual bar both at law and in equity as against the Escrow Agent, the Company and Fulcrum. The Escrow Agent's responsibilities and liabilities hereunder will terminate upon transfer by Escrow Agent of the Escrowed Shares under this Agreement.
5. Notices. Any notice or other communication required or permitted to be given hereunder shall be in writing and shall be (a) delivered by hand, (b) facsimile, or (c) overnight delivery with proper postage prepaid, and addressed as follows:
(i) If to the Company:
Scientific Industries, Inc.
70 Orville Drive.
Bohemia, New York, New York 11716
Attention: Helena R. Santos, Chief Executive Officer
Facsimile Number: (631) 567-5896
With a copy to:
Reitler Kailas & Rosenblatt LLC
885 Third Avenue, 20th Floor
New York, New York 10022
Attention: Leo Silverstein, Esq.
Facsimile Number: (212) 371-5500
(ii) If to Fulcrum:
Fulcrum, Inc.
100 Delawanna Avenue, Suite 502
Clifton, New Jersey 07014
Attention: James Maloy, President
Facsimile Number: (978) 461-2515
With a copy to:
Jeffrey Marks, Esq.
Law Officers of Jeffrey D. Marks PC
415 Clifton Avenue
Clifton, NJ 07014
Facsimile Number: (973) 777-8302
(iii) If to the Escrow Agent:
Reitler Kailas & Rosenblatt LLC
885 Third Avenue, 20th Floor
New York, New York 10022
Attention: John Watkins, Esq.
Facsimile Number: (212) 371-5500
or to such other address as the person to whom notice is to be given may have previously furnished to the others in the above-referenced manner. Except as otherwise provided herein, no notice or communication shall be effective until received.
6. Miscellaneous.
(a) Conflict. Reitler Kailas & Rosenblatt LLC is counsel to Company in this transaction and has in the past been counsel to the Company and certain of its affiliates. Both Company and Fulcrum consent to the additional appointment of Reitler Kailas & Rosenblatt LLC as Escrow Agent for this transaction. Both the Company and Fulcrum acknowledge that, in acting as Escrow Agent, Reitler Kailas & Rosenblatt LLC is not acting as attorneys for Fulcrum. Fulcrum consents to Reitler Kailas & Rosenblatt LLC continued and future representation of the Company and its affiliates and agree not to assert any such conflict of interest or to seek to disqualify the firm or its partners from representing the Company or an affiliate of the Company notwithstanding any dispute that may develop between Fulcrum and the Company other than a dispute between the Company and Fulcrum as to the Escrow Agreement or enforcement of its terms.
(b) Binding Effect. This Agreement shall be binding upon, and inure solely to the benefit of, the parties hereto and their respective successors and assigns, heirs and administrators and shall not be enforceable by, or inure to the benefit of, any other third party, except as provided in paragraph (vi) of Section 4(b) with respect to the termination of, or resignation by, the Escrow Agent. No party may assign any of its rights or obligations under this Agreement without the
written consent of the other parties.
(c) Choice of Law. This Agreement shall be construed in accordance with, and governed by, the internal law of the State of New York (without reference to its rules as to conflicts of law).
(d) Modification. This Agreement may only be modified by a writing signed by the Company, the Escrow Agent and Fulcrum.
(e) Headings. The section headings herein are for convenience only and shall not affect the construction thereof. Unless otherwise indicated, references to Sections and Articles are to Sections and Articles, respectively, contained herein.
(f) Counterparts; Facsimile. This Agreement may be executed in one or more counterparts (each of which may be transmitted via email or facsimile) but all such separate counterparts shall constitute but one and the same instrument; provided that, although executed in counterparts, the executed signature pages of each such counterpart may be affixed to a single copy of this Agreement which shall constitute an original.
(g) Conflicting Language. In the event of a conflict between Company and Fulcrum relating to the language of this Agreement and the language of the Purchase Agreement, as between the Company and Fulcrum, the language of the Purchase Agreement shall control between them.
(h) Termination. The escrow created pursuant to this Escrow Agreement shall terminate at the time that the Escrowed Shares have been delivered in accordance herewith, and all obligations of Fulcrum and Company to the Escrow Agent shall have been satisfied.
[Signature Page Follows]
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the day and year first above written.
SCIENTIFIC INDUSTRIES, INC.
/s/ Helena R. Santos By:________________________________ Name: Helena R. Santos Title: President |
FULCRUM, INC.
By: /s/ James Maloy ___________________ Name: James Maloy Title: President |
ESCROW AGENT:
REITLER KAILAS & ROSENBLATT LLC
/ Reitler kailas & Rosenblatt LLC
By:________________________________
Name:
Title:
Employment Agreement
This Employment Agreement (this "Agreement") dated as of February 26, 2014 (the "Effective Date") is made by and between SCIENTIFIC INDUSTRIES, INC., a Delaware corporation (the "Company") and KARL NOWOSIELSKI, who resides at 139 Pascack Rd. Pearl River NY 10965, (the "Employee").
WITNESSETH:
WHEREAS, in connection with, and as a condition, to the acquisition by the Company of certain assets of Fulcrum, Inc., a New Jersey corporation ("Assignor"), relating to the research, development, production, marketing and sale of the laboratory, analytical and pharmacy balance and digital scale products, including the Torbal DrX3 mechanical scale, pill counters, moisture analyzers, industrial scales, force gauges, and related systems, methods and processes (collectively, the "Scale and Balance Business") pursuant to that certain Asset Purchase Agreement by and between the Company and Fulcrum dated as of the date of the Effective Date (the "APA"), the Company desires to have the benefit of the employment of Employee, and Employee wishes to be so employed by the Company on the terms and conditions hereinafter contained.
NOW, THEREFORE, it is hereby agreed as follows:
1. Employment: Employee is hereby employed as (i) President of the Company's new Torbal Scales Division housing its Scale and Balance Business and (ii) Director of Marketing of the Company for the Term, as defined in Paragraph 2 below, to perform the duties described in Paragraph 3 hereof.
2. Employment Term: Subject to the terms of Paragraph 7 below, the term of employment of Employee by the Company pursuant to this Agreement shall be for three years commencing on the Effective Date, which may be extended by mutual agreement of the parties for an additional two years by providing written notice to the other party of the extension at least 90 days prior to the end of the term and the agreement of the party receiving such notice by written notice to the other party at least 45 days prior to the end of the then current term of such agreement. The period of employment from the Effective Date until the last date of employment (the "Termination Date") pursuant to this Agreement is herein referred to as the "Term".
3. Employee Duties: Employee shall devote his full time and attention to the business and affairs of the Company's Torbal Scales Division, performing those duties typically necessary for the management and performance of tasks to effect and to ensure the smooth running of the Company's Torbal Scales Division's operations, including duties related to, but not limited to, sales, marketing, production, engineering and administration, in each case as reasonably designated by the Company's Chief Executive Officer (the "CEO") or the Executive Vice-President of the Company related to the Scale and Balance Business, as defined above,
operating from a facility located in New Jersey, and to travel as may reasonably be required in performance of the duties. In addition, as time permits, Employee shall perform tasks related to the Company's marketing efforts as reasonably required and requested by the Company's CEO. He shall report directly to the Chief Executive Officer of the Company.
4. Compensation: During the Term, Employee shall be paid by the Company a salary at the rate of $140,000 per annum payable in equal installments consistent with the salary installments payable to other regular employees, currently weekly. The salary shall be adjusted on each anniversary of the Effective Date commencing with the second year of the Term to reflect the percentage increase, if any, in the Consumer Price Index for all urban consumers as published by the U.S. Bureau of Labor Statistics ("CPI") at the end of the immediately preceding year over the CPI as of the beginning of such year (measured in each case from the nearest date on or prior to the relevant anniversary date of the Term for which CPI data is published). At the sole and absolute discretion of the Board of Directors, the Company may pay Employee a bonus in addition to the foregoing compensation in recognition of his services and the results of the Company's operation for each fiscal year of the Company during the Term (pro rata for year ending June 30, 2014).
5. Expenses: Subject to the approval of the President or CEO of the Company, Employee is authorized to incur reasonable and necessary expenses in connection with the discharge of his duties and in promoting the business of the Company, including travel expenses to travel between the Company's New Jersey location and the Bohemia, NY headquarters reimbursable at the current IRS mileage rate, plus tolls. During the Term, the Company will provide Employee with a cellular phone and a laptop computer. All equipment including computers and telephones provided to Employee by the Company for fulfillment of his duties shall remain the property of the Company and shall, at the request of the Company, upon expiration or early termination of the Term be promptly delivered to the Company.
6. Options. The Company agrees to grant to Employee under its 2012 Stock Option Plan (the "Plan") qualified stock options ("QSOs") to purchase 2,000 shares of its Common Stock exercisable at the per share price equal to the fair market value on the Effective Date as determined under the Plan. Scientific agrees to grant to Employee (i) on the first anniversary of the Effective Date, QSOs to purchase 4,000 shares of Company Common Stock, (ii) on the second anniversary of the Effective Date, QSOs to purchase 5,000 shares of Company Common Stock, and (iii) on the third anniversary of the Effective Date, QSOs to purchase 6,000 shares of the Company's Commons Stock, in each case subject to the continued employment of Employee under this Agreement as of such dates and in each case such QSOs shall be fully vested as of the relevant grant date and shall have an exercise price equal to the fair market value of a share of Common Stock as of the relevant grant date as determined under the Plan.
7. Other Benefits: During the Term, Employee shall be entitled to receive benefits from the Company consistent with those provided to other employees of the Company having similar periods of service, including medical, hospital, dental, life, disability benefits, 401(K), four weeks paid vacation, and sick leave, subject in each instance to eligibility standards.
8. Termination By the Company Due to Death, Disability or Cause; Termination by Employee for Good Reason or the Company Without Cause:
a. In the event of Employee's death during the Term, this Agreement shall terminate automatically as of the date of death, except with respect to any accrued but unsatisfied obligations as to salary, benefits (other than the grant of options pursuant to Section 6) and expense reimbursements to the date of death.
b. In the event of the Employee's Disability (as hereinafter defined) during the Term for ninety (90) consecutive calendar days or one hundred twenty (120) calendar days in the aggregate during any consecutive twelve (12) month period, the Company shall have the right, by written notice to Employee, to terminate this Agreement effective upon delivery of such notice to Employee. Employee shall be entitled to receive all accrued but unsatisfied obligations as to salary, benefits, and expense reimbursements as of the effective date of such termination. "Disability" for the purposes of this Agreement shall mean Employee's physical or mental disability, as determined in good faith by the President or CEO, and confirmed by a medical provider, in the field of the claimed Disability, of the Company's choice, reasonably acceptable to Employee (or his legal representative), so as to render him incapable of carrying out his essential duties under this Contract.
c. The Company shall have the right to discharge Employee
and terminate this Agreement (except Paragraphs 9 and 10 shall
survive any such termination and remain in full force and effect),
for "Cause" (as hereinafter defined) (i) if capable of cure, upon
the failure of Employee to cure the Cause by the end of the thirtieth
(30th) day following delivery of written notice of such termination
to Employee setting forth the Cause or (ii) if not capable of cure,
immediately upon delivery of written notice of such termination to
Employee setting forth the Cause. "Cause" shall mean (A) Employee's
commission of a felony or entry of a plea of nolo contendere to a
felony charge, (B) gross neglect or gross misconduct (including
conflict of interest) in the carrying out of Employee's duties
under this Agreement, (C) Employee's failure, refusal or neglect
to perform Employee's duties in accordance with Paragraph 3 hereof,
(D) engaging in an act or acts of dishonesty affecting the Company
or its subsidiaries, (E) alcohol abuse or the illegal use of drugs,
or (F) Employee's material breach of this Agreement, in each case
in a manner materially interfering with performance of Employee's
obligations under this Agreement.
d. Employee may terminate his employment for "good reason" in the event of (i) material breach by the Company of this Agreement, or (ii) a significant change in Employee's responsibilities or duties, in either case, which breach or change remains uncured for a period of thirty (30) days following the Company's receipt of written notice of such breach.
e. In the event of a termination of Employee's employment under this Agreement by the Company without "Cause" or termination by Employee for "good reason" pursuant to Paragraph 8(d) above, the Company shall (i) pay to Employee (A) Severance Pay (as defined below), (B) salary and benefits accrued and payable up to the date of such termination, and (C) reimbursement of those expenses accrued and payable under Paragraph 7 hereof through the effective termination date; and (ii) continue to provide Employee with such health and medical benefits required to be provided by the Company pursuant to Paragraph 7 during the Term, for a period of twenty four (24) months immediately following the effective date of Employee's termination. Severance Pay shall be defined as one year's salary at the rate of the compensation Employee is receiving at the time of termination. All payments of Severance Pay shall be payable in accordance with Company payroll practice (currently weekly) over the 12-month period following the effective date of Employee's termination
f. The Company agrees to provide Employee with an office
located within a 20-mile radius of employee's current residence
listed above provided, however, Employee may work from home to
the extent his presence at the Company's office is not required
in connection with the performance of his obligations under this
Agreement, subject to the reasonable consent of the Company.
.
9. Confidential Information.
a. Employee agrees that during and after the Term he will not, directly or indirectly, disclose to any person, or use or otherwise exploit for the benefit of Employee or for the benefit of anyone other than the Company, any Confidential Information (as defined in Paragraph 9(c)). Employee shall have no obligation hereunder to keep confidential any Confidential Information if and to the extent disclosure of any thereof is specifically required under applicable law; provided, however, that in the event disclosure is so required, Employee, to the extent legally permitted, shall provide the Company with prompt notice of such requirement, prior to making any disclosure, so that the Company may seek an appropriate protective order.
b. At the request of the Company, Employee agrees to deliver to the Company, at any time during the Term, or thereafter, all Confidential Information which Employee may possess or control. Employee agrees that all Confidential Information of the Company (whether now or hereafter existing) conceived, discovered or made by Employee during the Term exclusively belongs to the Company (and not to Employee). Employee will promptly disclose such
Confidential Information to the Company and perform all actions reasonably requested by the Company to establish and confirm such exclusive ownership.
c. "Confidential Information" means any confidential information of the Company or its subsidiaries or affiliates including, without limitation, any patent, patent application, copyright, trademark, trade name, service mark, service name, "know-how", trade secrets, customer lists, vendor lists, customer pricing or terms, details of client or consultant contracts, pricing policies, cost information, operational methods, financial and accounting information, marketing plans or strategies, product development techniques or plans, business acquisition plans or any portion or phase of any business, scientific or technical information, ideas, discoveries, designs, computer programs (including source or object codes), processes, procedures, formulae, improvements, information relating to the products and services currently being sold, developed or contemplated, by the Company, or which hereinafter may be sold, developed or contemplated, by the Company through the date of termination of the Term, including, but not limited to, pharmaceutical or laboratory balances and scale products or components, catalytic research instruments, mixers, including vortex mixers, rotating, shaking or oscillating apparatuses; thermoelectric apparatuses, sensors or bioreactor bags; bioprocessing systems operations; or any industrial or laboratory processes, apparatuses or equipment relating thereto or other proprietary or intellectual property of the Company, whether or not in written or tangible form, and whether or not registered, and including all memoranda, notes, summaries, plans, reports, records, documents and other evidence thereof. The term "Confidential Information" does not include, and there shall be no obligation hereunder with respect to, information that becomes generally available to the public other than as a result of a disclosure by Employee not permissible hereunder.
d. Notwithstanding anything herein to the contrary, this Paragraph 9 shall survive any termination of this Agreement.
10. Non-Competition.
a. Subject to the Company not then being in default of its obligations under this Agreement, and subject to the provisions of paragraph 8 of this Agreement,, Employee agrees that for a period ending on a date which is twelve (12) months following the last day of his employment by the Company or a subsidiary of the Company (the "Non-Competition Period"), he shall not:
i. engage directly or indirectly in the "Restricted Area"
as defined below in: (x) the Scale and Balance Business; (y)
the business of developing, producing, marketing or selling:
(A) pharmaceutical and laboratory balances or scales or
components, or (B) items (products or services) which the
Company or one of its subsidiaries or an affiliate thereof
during the Term is developing, producing, marketing or selling,
or (C) items (products or services) which the Company has
advised Employee during the Term, it or a subsidiary or
affiliate intends to produce or sell
(collectively the
"Non-Competition Activities") or;
ii. perform services (including without limitation as an employee, independent contractor, officer, director or consultant) for, or otherwise be engaged by or have any financial interest in or affiliation with any individual, corporation, partnership or any other entity substantially involved in the Non-Competition Activities ("Competitor Entity") or;
iii. own, along with his affiliates, including parents, siblings and members of their families, directly or indirectly (the "Employee Group"), at least 2% in the aggregate of the outstanding equity interests of any Competitor Entity; provided, however, that nothing contained in this Paragraph 10(a) shall prevent Employee from purchasing as an investment securities of any corporation whose securities are regularly traded on any national securities exchange or in the over-the-counter market if such purchase would not result in the Employee Group owning at the time of the purchase more than 3% of the outstanding equity interests of the Competitor Entity.
"Restricted Area" shall mean the United States, Canada, Central and South America.
b. During the Non-Competition Period and subject to the Company's not being in material breach of the terms of this Agreement, Employee shall not solicit or induce any employee of the Company or a subsidiary or affiliate of the Company, to leave its employ.
c. If the final judgment of a court of competent jurisdiction declares that any term or provision of Paragraphs 10(a) or (b) above, is invalid or unenforceable, the parties to this Agreement agree that the court making the determination of invalidity or unenforceability shall have the power to reduce the scope, duration or area of the term or provision, to delete specific words or phrases, or to replace any invalid or unenforceable term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be enforceable as so modified.
d. Notwithstanding anything herein to the contrary, this Paragraph 10 shall survive any termination of this Agreement other than as a result of a termination of Employee's employment (i) by the Company without "Cause" during the initial three-year term of this Agreement or any subsequent renewal term or (ii) by Employee for "good reason" pursuant to Paragraph 8(e) of this Agreement.
11. Remedies.
a. Nothing herein contained is intended to waive or diminish any rights the Company may have at law or in equity at any time to protect and defend its legitimate property interests including its business relationships with third parties, the foregoing provisions being intended to be in addition to and not in derogation or limitation of any other rights it may have at law or in equity.
b. A breach by Employee of the provisions of Paragraphs 9 or 10 above, or the failure of the Employee to discontinue any action within two business days following written notice from the Company to Employee to discontinue such action which if consummated would constitute a breach of the provisions of Paragraphs 9 or 10 above, may cause the Company or any of its subsidiaries or affiliates, irreparable injury and damage. Employee therefore agrees that damages may be an inadequate remedy and the Company on behalf of itself or its subsidiaries or affiliates shall be entitled to injunctive and/or other equitable relief to prevent any breach of such Paragraph of this Agreement and to secure its enforcement, without being required to provide any security or post any bond.
12. For Hire: The Company shall own forever and throughout the world all rights of any kind or nature now or hereafter known in and to all of the product of Employee's employment hereunder in any capacity and any and all parts thereof, including, without limitation, patents (exclusively during the current and renewed or extended term of the patent issued anywhere in the world and thereafter, non-exclusively), trade names, trademarks, copyrights and all other property or property rights in or to any ideas, concepts, designs, drawings, plans, prototypes, or any other similar creative works and to the product of any or all of such services, Employee acknowledging and agreeing that the foregoing purposes, Employee is performing his services as the Company's employee-for-hire. Without limiting the generality of the previous sentence, Employee acknowledges and agrees that all memoranda, notes, records, and other documents made or compiled by Employee or made available to Employee during his employment by the Company concerning the business of the Company and its subsidiaries shall be the property of the Company or its subsidiaries, as the case may be, and shall be delivered by Employee to the Company, upon termination of this Agreement or at any other time at the Company's request.
13. Notices: Any notices pertaining to this Agreement if to the Company shall be addressed to: Scientific Industries, Inc., 70 Orville Drive, Bohemia, New York, 11716, Attention: Chief Executive Officer, Fax no. 631-567-5896, with copy to be sent to Reitler Kailas & Rosenblatt LLC, 885 Third Avenue, 20th floor, New York, NY 10022, Attention: John Watkins, Esq., Fax no. 212-371-5500; and if to Employee shall be addressed to Karl Nowosielski, 139 Pascack Rd. Pearl River NY 10965, with a copy to Jeffrey D. Marks Esq., 415 Clifton Avenue, Clifton, New Jersey 07011, Fax no. 973-253-8858. All notices shall be in writing and shall be deemed duly given if personally delivered or sent by registered or certified mail, overnight or express mail or courier, or by e-mail or fax. If sent by registered or certified mail, notice shall be deemed to have been received and effective three days after mailing; if by overnight or express mail or courier or by e-mail or fax (with evidence of successful transmission/dispatch), notice shall be deemed received the next business day after being sent. Any party may change its address for notice hereunder by giving notice of such change in the manner provided in this Paragraph 13.
14. Entire Agreement: This Agreement contains the entire agreement of the parties, respecting the subject matter contained herein. No modification of any provision hereof shall be effective except by a written agreement signed by the parties hereto. This Agreement may be executed in counterparts (each of which may be transmitted via facsimile) with the same effect as if all parties had signed the same document, and all counterparts shall be construed together and shall constitute the same instrument.
15. Miscellaneous:
a. This Agreement shall be deemed to have been made in the State of New York and shall be governed by and construed in accordance with the laws of the State of New York without regard to conflict of law rules thereof.
b. The Agreement shall be binding upon and inure to the benefit of the parties, their respective successors, heirs and assigns (where permitted).
c. The waiver by one party hereto of any breach by the other (the "Breaching Party") of any provision of the Agreement shall not operate or be construed as a waiver of any other (prior or subsequent) breach by the Breaching Party, and waiver of a breach of a provision in one instance shall not be deemed a waiver of a breach of such provision in any other circumstance.
IN WITNESS WHEREFOR, the parties hereto have signed this Agreement as of the year and date first above written.
SCIENTIFIC INDUSTRIES, INC.
/s/ Helena R. Santos By:_________________________________________ Helena R. Santos Chief Executive Officer |
KARL NOWOSIELSKI
/s/ KARL NOWOSIELSKI _____________________________________________ |
CONTRACT No. 03/EX/2014
On 02.20.2014, AXIS Sp. z o.o. ul. Kartuska 375B 80-125 Gdansk, Poland, hereinafter referred to as the SUPPLIER, represented by its Director, Mr. Leonard Kosecki, acting pursuant to the Articles of Association, on the one hand, and Scientific Industries Inc. 70 Orville Drive, Bohemia, New York 11716, hereinafter referred to as the CUSTOMER, represented by CEO and President Mrs. Helena Santos, acting pursuant to the Articles of Association, on the other hand, executed the contract on cooperation under the following terms and conditions.
Article 1: Products and Territory.
1.1 The SUPPLIER shall sell, whereas the CUSTOMER shall purchase
any products, hereinafter referred to as the PRODUCTS, included in
the price list provided to the CUSTOMER by the SUPPLIER.
1.2 The SUPPLIER shall manufacture its products with the
CUSTOMER's logo and name. SUPPLIER declares to manufacture products
with CUSTOMER's logo or company name only for the CUSTOMER in
accordance with this agreement.
1.3 The CUSTOMER, at its own expense, shall ensure certification
of the PRODUCTS.
1.4 The CUSTOMER undertakes not to manufacture, at its own, the PRODUCTS listed in the certificates during the term of the contract. Only the SUPPLIER shall have the right to manufacture and supply the PRODUCTS to the CUSTOMER.
1.5 The CUSTOMER may operate in all the countries of North America, South America and Latin America, hereinafter referred to as the TERRITORY. The CUSTOMER shall enjoy the exclusive right to sell the PRODUCTS on the territory of the United States and Canada. In other countries of the TERRITORY, the SUPPLIER may develop its own sales networks and sell the products with its own logo.
Article 2: Good faith and fair conduct of business.
2.1. While fulfilling their obligations under the contract,
the Parties shall act in good faith and conduct business in a
fair manner.
2.2. The provisions of the contract as well as any
representations of the Parties in connection herewith shall
be interpreted in good faith.
2.3. A dismissal by the CUSTOMER of Mr. Karol Nowosielski
from work without cause (not in accordance with the employment
contract) allows the SUPPLIER to terminate this agreement with
a 6 month notice.
Article 3: Dealers and Agents.
3.1. The CUSTOMER may appoint dealers and agents to sell the
Products on the Territory. The
CUSTOMER may request and ask the SUPPLIER for permission to sell
the products on other territories. The Supplier shall grant its
consent at its own discretion.
3.2. The CUSTOMER shall be responsible for its own dealers
and agents.
Article 4: Obligation to keep the Supplier informed.
4.1. The CUSTOMER shall exercise due diligence in informing the SUPPLIER of its operations, market conditions and status of the competition within its Territory. The CUSTOMER shall answer to any reasonable request for information, submitted by the SUPPLIER.
Article 5: Currency and sale/resale prices of goods.
5.1. The prices of the PRODUCTS shall be determined by the
SUPPLIER in Polish Zlotys (PLN). For the purpose of mutual
settlements, the prices in PLN have been converted into USD at
the exchange rate indicated in the price list. In case of
change of an average PLN/USD exchange rate (published by the
National Bank of Poland) by more than 3%, the SUPPLIER shall
amend the price list. SUPPLIER agrees not change prices
expressed in PLN until the end of this year. SUPPLIER agrees
not to change prices for a period of 120 days from the date of
this agreement which are expressed in USD as long as the
exchange rate is 1USD = 2.95PLN. If the exchange rate is less
than 1USD=2.95PLN the price list will be adjusted. The initial
exchange rate in the price list is set to be 1USD=3.1PLN 5.2.
The SUPPLIER will inform the CUSTOMER 30 days in advance of
any plans to increase prices on its PRODUCTS which are
expressed in PLN.
5.3. The CUSTOMER shall enjoy freedom in determining the
resale prices of the Products in the Territory.
Article 6: Obligation to keep the Customer informed.
6.1. The SUPPLIER shall provide the CUSTOMER free of charge with the entire documentation related to the Products, necessary to operate the technical support and develop advertising materials (maintenance manuals, operating manuals in Polish or English, explanations, photographs etc.) as reasonably required by the CUSTOMER to perform its obligations related to performance of this contract.
6.2. SUPPLIER will inform the CUSTOMER at least 90 days in advance of any design and software changes to the scales. SUPPLIER will verify all significant changes to the construction, technology, or firmware with the CUSTOMER. No significant change will be implemented without the consent of the customer. CUSTOMER will not withhold any reasonable proposed changes by the supplier.
Article 7: Term of the agreement and the guarantor's obligations.
7.1. The Contract shall become effective upon signing thereof and shall remain valid until 03.01.2020. After the date of 03.01.2020 either party shall have the right to terminate this agreement with a one year notice.
7.2. The CUSTOMER shall assume the obligations of the guarantor
of the PRODUCTS purchased by it from the SUPPLIER.
7.3. The SUPPLIER shall have the right to return, exchange or
receive a credit for the products, which do not satisfy the
requirements and do not work in accordance with the product
specifications.
Article 8: Payment.
8.1. Payments for the invoices shall be made in $ (USD) by
electronic transfer to the SUPPLIER's bank account.
8.2. The costs of the electronic transfer shall be covered
in full by the CUSTOMER.
8.3. The payments shall be made in full within 30 days of
shipment.
8.4. The payments shall be made under the terms agreed
(CPT, CIF, FOB, EXW etc.).
8.5. A failure to make a timely payment for the shipped
goods shall entitle the Supplier to cease
further shipments until payment of the outstanding amounts.
8.6. The sum of the invoices not paid by the CUSTOMER shall
not exceed the maximum of $100,000.00 (one hundred thousand USD).
Article 9: Early termination.
9.1. Either party shall have the right to terminate this
contract with immediate effect by a written notice ensuring the
evidence and date of receipt confirmation (for instance,
registered mail with return receipt confirmation, special
courier etc.), in case of a material breach by the other party
of the obligations hereunder, or in case of exceptional
circumstances substantiating the early termination listed in
paragraph 9.2. The SUPPLIER may terminate this agreement upon
60 days prior written notice in the case of inadequate purchasing
volume, less than 150.000USD in 2014 and less than 180.000USD
in subsequent years.
9.2. The Parties agree that the following events shall be
regarded inter alia as exceptional circumstances substantiating
the early termination of the contract by the other party:
bankruptcy, moratorium, receivership, liquidation or any other
agreement whatsoever between the debtor and the creditors, or
any other circumstances, which a likely to affect the party's
ability to full fill its obligations hereunder.
Article 10: Governing Law.
10.1. Where a dispute between the parties cannot be settled
through negotiations, the parties' claims shall be referred
for resolution to the Arbitration Court in Gda?sk, Poland.
10.2. The decisions of the Arbitration Court shall be binding
upon both parties.
Article 11: Authentic text.
11.1. The Polish text of this agreement shall be considered
as the only authentic text.
11.2. This agreement is contained in the eleven articles on
three pages of the text of the agreement.
DOSTAWCA: ODBIORCA: AXIS Sp. z o.o. Scientific Industries Inc. ul. Kartuska 375B 70 Orville Drive 80-125 Gda?sk, Bohemia, New York 11716 Poland USA Phone: + 48 58 3206301 Phone # + 1 (631) 567-4700 Fax + 48 58 3206300 Fax # + 1 (631) 567-5896 /s/ Kosecki Leonard /s/ Helena Santos .................... ................. Kosecki Leonard Helena Santos |